<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:07:12Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5839554" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5839554</identifier><datestamp>2018-03-28</datestamp><setSpec>brain</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Brain</journal-id>
      <journal-id journal-id-type="iso-abbrev">Brain</journal-id>
      <journal-id journal-id-type="publisher-id">brainj</journal-id>
      <journal-id journal-id-type="hwp">brain</journal-id>
      <journal-title-group>
        <journal-title>Brain</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-8950</issn>
      <issn pub-type="epub">1460-2156</issn>
      <publisher>
        <publisher-name>Oxford University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5839554</article-id>
      <article-id pub-id-type="pmcid">PMC5839554</article-id>
      <article-id pub-id-type="pmc-uid">5839554</article-id>
      <article-id pub-id-type="pmid">26556829</article-id>
      <article-id pub-id-type="pmid">26556829</article-id>
      <article-id pub-id-type="doi">10.1093/brain/awv320</article-id>
      <article-id pub-id-type="publisher-id">awv320</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>
ALS5/SPG11/
<italic>KIAA1840</italic>
mutations cause autosomal recessive axonal CharcotâMarieâTooth disease
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Montecchiani</surname>
            <given-names>Celeste</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pedace</surname>
            <given-names>Lucia</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lo Giudice</surname>
            <given-names>Temistocle</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF1">1</xref>
          <xref ref-type="aff" rid="awv320-AFF2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Casella</surname>
            <given-names>Antonella</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mearini</surname>
            <given-names>Marzia</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gaudiello</surname>
            <given-names>Fabrizio</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pedroso</surname>
            <given-names>JosÃ© L.</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Terracciano</surname>
            <given-names>Chiara</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Caltagirone</surname>
            <given-names>Carlo</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF2">2</xref>
          <xref ref-type="aff" rid="awv320-AFF4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Massa</surname>
            <given-names>Roberto</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>St George-Hyslop</surname>
            <given-names>Peter H.</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF5">5</xref>
          <xref ref-type="aff" rid="awv320-AFF6">6</xref>
          <xref ref-type="aff" rid="awv320-AFF7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barsottini</surname>
            <given-names>Orlando G. P.</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kawarai</surname>
            <given-names>Toshitaka</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF8">8</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Orlacchio</surname>
            <given-names>Antonio</given-names>
          </name>
          <xref ref-type="aff" rid="awv320-AFF1">1</xref>
          <xref ref-type="aff" rid="awv320-AFF2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="awv320-AFF1">
<label><sup>1</sup></label>
1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy
</aff>
      <aff id="awv320-AFF2">
<label><sup>2</sup></label>
2 Dipartimento di Medicina dei Sistemi, UniversitÃ  di Roma âTor Vergataâ, Rome, Italy
</aff>
      <aff id="awv320-AFF3">
<label><sup>3</sup></label>
3 Department of Neurology, Universidade Federal de SÃ£o Paulo, Brazil
</aff>
      <aff id="awv320-AFF4">
<label><sup>4</sup></label>
4 Laboratorio di Neurologia Clinica e Comportamentale, IRCCS Santa Lucia, Rome, Italy
</aff>
      <aff id="awv320-AFF5">
<label><sup>5</sup></label>
5 Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada
</aff>
      <aff id="awv320-AFF6">
<label><sup>6</sup></label>
6 Department of Medicine, University of Toronto, Toronto, Ontario, Canada
</aff>
      <aff id="awv320-AFF7">
<label><sup>7</sup></label>
7 Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
</aff>
      <aff id="awv320-AFF8">
<label><sup>8</sup></label>
8 Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
</aff>
      <author-notes>
        <corresp>
Correspondence to: Prof. Antonio Orlacchio, Laboratorio di Neurogenetica, Centro Europeo di Ricerca sul Cervello (CERC) - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Santa Lucia, 64 Via del Fosso di Fiorano, Rome 00143, Italy E-mail:
<email>a.orlacchio@hsantalucia.it</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date iso-8601-date="2015-11-10" pub-type="epub">
        <day>10</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>10</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>139</volume>
      <issue>1</issue>
      <fpage>73</fpage>
      <lpage>85</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>3</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>
), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="awv320.pdf"/>
      <abstract abstract-type="teaser">
        <p>
Mutations in the ALS5/SPG11/
<italic>KIAA1840</italic>
gene cause autosomal recessive hereditary spastic paraplegia or autosomal recessive juvenile amyotrophic lateral sclerosis. Montecchiani
<italic>et al</italic>
. show that
<italic>KIAA1840</italic>
mutations can manifest also as recessive Charcot-Marie-Tooth disease. They describe 12 kindreds with 15 different mutations, two of which have not been reported previously.
</p>
      </abstract>
      <abstract abstract-type="graphical">
        <p>
<fig id="fig1g" orientation="portrait" position="float"><caption><p>
Mutations in the ALS5/SPG11/
<italic>KIAA1840</italic>
gene cause autosomal recessive hereditary spastic paraplegia or autosomal recessive juvenile amyotrophic lateral sclerosis. Montecchiani
<italic>et al</italic>
. show that
<italic>KIAA1840</italic>
mutations can manifest also as recessive Charcot-Marie-Tooth disease. They describe 12 kindreds with 15 different mutations, two of which have not been reported previously.
</p></caption><graphic xlink:href="awv320fig1g"/></fig>
</p>
      </abstract>
      <abstract>
        <title>Abstract</title>
        <p>
CharcotâMarieâTooth disease is a group of hereditary peripheral neuropathies that share clinical characteristics of progressive distal muscle weakness and atrophy, foot deformities, distal sensory loss, as well as diminished tendon reflexes. Hundreds of causative DNA changes have been found, but much of the genetic basis of the disease is still unexplained. Mutations in the ALS5/SPG11/
<italic>KIAA1840</italic>
gene are a frequent cause of autosomal recessive hereditary spastic paraplegia with thin corpus callosum and peripheral axonal neuropathy, and account for â¼40% of autosomal recessive juvenile amyotrophic lateral sclerosis. The overlap of axonal CharcotâMarieâTooth disease with both diseases, as well as the common autosomal recessive inheritance pattern of thin corpus callosum and axonal CharcotâMarieâTooth disease in three related patients, prompted us to analyse the ALS5/SPG11/
<italic>KIAA1840</italic>
gene in affected individuals with autosomal recessive axonal CharcotâMarieâTooth disease. We investigated 28 unrelated families with autosomal recessive axonal CharcotâMarieâTooth disease defined by clinical, electrophysiological, as well as pathological evaluation. Besides, we screened for all the known genes related to axonal autosomal recessive CharcotâMarie-Tooth disease (CMT2A2/HMSN2A2/
<italic>MFN2</italic>
, CMT2B1/
<italic>LMNA</italic>
, CMT2B2/
<italic>MED25</italic>
, CMT2B5/
<italic>NEFL</italic>
, ARCMT2F/dHMN2B/
<italic>HSPB1</italic>
, CMT2K/
<italic>GDAP1</italic>
, CMT2P/
<italic>LRSAM1</italic>
, CMT2R/
<italic>TRIM2</italic>
, CMT2S/
<italic>IGHMBP2</italic>
, CMT2T/
<italic>HSJ1</italic>
, CMTRID/
<italic>COX6A1</italic>
, ARAN-NM/
<italic>HINT</italic>
and GAN/
<italic>GAN</italic>
), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/
<italic>PGN</italic>
, SPG15/
<italic>ZFYVE26,</italic>
SPG21/
<italic>ACP33</italic>
, SPG35/
<italic>FA2H</italic>
, SPG46/
<italic>GBA2</italic>
, SPG55/
<italic>C12orf65</italic>
and SPG56/
<italic>CYP2U1</italic>
), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (
<italic>SLC12A6</italic>
)
<italic>.</italic>
Mitochondrial disorders related to CharcotâMarieâTooth disease type 2 were also excluded by sequencing
<italic>POLG</italic>
and
<italic>TYMP</italic>
genes. An additional locus for autosomal recessive CharcotâMarieâTooth disease type 2H on chromosome 8q13-21.1 was excluded by linkage analysis. Pedigrees originated in Italy, Brazil, Canada, England, Iran, and Japan. Interestingly, we identified 15 ALS5/SPG11/
<italic>KIAA1840</italic>
mutations in 12 families (two sequence variants were never reported before, p.Gln198* and p.Pro2212fs*5). No large deletions/duplications were detected in these patients. The novel mutations seemed to be pathogenic since they co-segregated with the disease in all pedigrees and were absent in 300 unrelated controls. Furthermore,
<italic>in silico</italic>
analysis predicted their pathogenic effect. Our results indicate that ALS5/SPG11/
<italic>KIAA1840</italic>
is the causative gene of a wide spectrum of clinical features, including autosomal recessive axonal CharcotâMarieâTooth disease.
</p>
        <p>
<fig fig-type="video" id="vid1" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1093/brain/awv320_video_abstract</object-id><media xlink:href="awv320.mp4" content-type="brightcove" orientation="portrait" id="d35e405" position="anchor" mimetype="video"><object-id pub-id-type="referenceid">awv320_video_abstract</object-id></media></fig>
</p>
      </abstract>
      <kwd-group kwd-group-type="keywords">
        <kwd>
ALS5/SPG11/
<italic>KIAA1840</italic>
mutations
</kwd>
        <kwd>axonal degeneration</kwd>
        <kwd>CharcotâMarieâTooth disease</kwd>
        <kwd>spatacsin</kwd>
      </kwd-group>
      <counts>
        <page-count count="13"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>
Mutations in the ALS5/SPG11/
<italic>KIAA1840</italic>
gene, located on chromosome 15q21.1, cause autosomal recessive hereditary spastic paraplegia (ARHSP; OMIM #604360), frequently associated with thin corpus callosum and axonal peripheral neuropathy (
<xref rid="awv320-B67" ref-type="bibr">
Stevanin
<italic>et al.</italic>
, 2007
<italic>a</italic></xref>
,
<xref rid="awv320-B68" ref-type="bibr"><italic>b</italic></xref>
;
<xref rid="awv320-B44" ref-type="bibr">
Lo Giudice
<italic>et al.</italic>
, 2014
</xref>
), as well as autosomal recessive juvenile amyotrophic lateral sclerosis (ARJALS; OMIM %602099), characterized by slowly progressive spasticity of limb and facial muscles with distal amyotrophy of hands and feet (
<xref rid="awv320-B52" ref-type="bibr">
Orlacchio
<italic>et al.</italic>
, 2010
</xref>
). CharcotâMarieâTooth (CMT) disease is a hereditary peripheral neuropathy characterized by slowly progressive distal muscle weakness, atrophy, and mild sensory loss, primarily in lower limbs. It is the most common degenerative disorder of the peripheral nervous system, with a global prevalence of 1 in 2500 (
<xref rid="awv320-B70" ref-type="bibr">
Tazir
<italic>et al.</italic>
, 2013
</xref>
). Phenotypes are grouped within the hereditary motor and sensory neuropathies (HMSNs;
<xref rid="awv320-B21" ref-type="bibr">Dyck and Thomas, 2005</xref>
) and can be divided into demyelinating (CMT1), axonal (CMT2), and intermediate forms, on the basis of electrophysiological criteria as well as pathological features (
<xref rid="awv320-B22" ref-type="bibr">
Dyck
<italic>et al.</italic>
, 1968
</xref>
). In CMT2, peripheral nerves are neither enlarged nor hypertrophic, with normal or near-normal conduction velocities; the disease course is highly variable, ranging from mild to severe forms (
<xref rid="awv320-B23" ref-type="bibr">
Feely
<italic>et al.</italic>
, 2011
</xref>
;
<xref rid="awv320-B71" ref-type="bibr">
Tazir
<italic>et al.</italic>
, 2014
</xref>
). The subtypes belonging to ARCMT2 share common and distinctive clinical features, e.g. CMT2B2 is characterized by sensory deficits, whereas CMT2K is characterized by hoarse voice and vocal cord paresis (
<xref rid="awv320-B14" ref-type="bibr">
Claramunt
<italic>et al.</italic>
, 2005
</xref>
;
<xref rid="awv320-B41" ref-type="bibr">
Leal
<italic>et al.</italic>
, 2009
</xref>
). To date, ARCMT2 has been associated with mutations in only a few genes, and many forms are still unrecognized (
<xref rid="awv320-B5" ref-type="bibr">Bird, 1993-2015</xref>
). Recent advances in the molecular genetics of CharcotâMarieâTooth disease have contributed to the classification and diagnosis of this heterogeneous disease (
<xref rid="awv320-B39" ref-type="bibr">Jerath and Shy, 2015</xref>
).
</p>
      <p>
The overlap between CMT2 and hereditary spastic paraplegia (
<xref rid="awv320-B74" ref-type="bibr">
Timmerman
<italic>et al.</italic>
, 2013
</xref>
;
<xref rid="awv320-B24" ref-type="bibr">Fridman and Murphy, 2014</xref>
), as well as the fact that the ALS5/SPG11/
<italic>KIAA1840</italic>
gene product (spatacsin) is implicated in axonal maintenance and cargo trafficking (
<xref rid="awv320-B58" ref-type="bibr">
PÃ©rez-BrangulÃ­
<italic>et al.</italic>
, 2014
</xref>
), and the common autosomal recessive inherited findings of thin corpus callosum and CMT2 in three related patients, motivated us to investigate the ALS5/SPG11/
<italic>KIAA1840</italic>
gene in families with ARCMT2 with no causative gene identified.
</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec sec-type="subjects">
        <title>Patients</title>
        <p>
This study was performed according to a protocol reviewed and approved by the Ethics Committee of the
<italic>Istituto di Ricovero e Cura a Carattere Scientifico Santa Lucia</italic>
, Rome, Italy. After obtaining informed consent, patients were recruited by a network of neurologists in Italy, Brazil, Canada, England, and Japan, with a significant background in peripheral neuropathy.
</p>
        <p>
The study focused on 28 unrelated pedigrees with ARCMT2 and without genetic assessment. The diagnosis of ARCMT2 was based on neurological findings, familial history, along with neurophysiological characteristics (
<xref rid="awv320-B5" ref-type="bibr">Bird, 1993-2015</xref>
). Flexor and extensor muscle strength was assessed manually using the standard Medical Research Council Scale (
<xref rid="awv320-B47" ref-type="bibr">Medical Research Council, 1981</xref>
). The Functional Disability Scale and the CharcotâMarieâTooth Neuropathy Score assessed the staging of the disease (
<xref rid="awv320-B6" ref-type="bibr">
Birouk
<italic>et al.</italic>
, 1997
</xref>
;
<xref rid="awv320-B48" ref-type="bibr">
Murphy
<italic>et al.</italic>
, 2011
</xref>
).
</p>
        <p>
All affected subjects under the age of 18 were investigated for IQ through the Wechsler Intelligence Scales for Children IV, including the Wechsler Memory Scale (
<ext-link ext-link-type="uri" xlink:href="http://alpha.fdu.edu/psychology/WISCIV_Index.htm">http://alpha.fdu.edu/psychology/WISCIV_Index.htm</ext-link>
). According to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (
<xref rid="awv320-B1" ref-type="bibr">American Psychiatric Association, 2013</xref>
), mental retardation was considered when the IQ was â¤70 before the age of 18. Adults were evaluated by Mental Deterioration Battery (
<xref rid="awv320-B9" ref-type="bibr">
Carlesimo
<italic>et al.</italic>
, 1996
</xref>
) to assess cognitive impairment. Brain MRI was obtained in all affected individuals, with the exception of eight subjects. Haematological and biochemical profiles, as well as lysosomal enzyme assay of Î²-hexosaminidase A and B in peripheral blood leucocytes, were performed in at least one patient within each family. CSF analysis was available in 21 patients. Vitamins B
<sub>1</sub>
, B
<sub>2</sub>
, B
<sub>6</sub>
, B
<sub>9</sub>
, B
<sub>12</sub>
, and E were measured in all patients.
</p>
        <p>Nerve conduction study was carried out with a surface skin temperature between 32Â°C and 34Â°C. Nerves were analysed bilaterally in upper and lower limbs using percutaneous stimulation and surface recording electrodes. Concentric needle EMG was performed in muscles of upper and lower limbs: spontaneous activity, duration, and amplitude of motor unit action potentials, as well as motor unit action potentials, interference pattern during maximal voluntary contraction, were recorded.</p>
        <p>
Sural nerve biopsy was available in 25 patients. Light microscopy preparations, and the electron microscopic analysis in one patient, were performed according to standard methods (
<xref rid="awv320-B54" ref-type="bibr">
Palumbo
<italic>et al.</italic>
, 2002
</xref>
).
</p>
      </sec>
      <sec>
        <title>Genetic analyses</title>
        <p>
Genomic DNA was extracted from peripheral blood using the Promega WizardÂ® Genomic DNA isolation kit. Linkage study of the 28 families with ARCMT2 was performed using microsatellite markers flanking the ALS5/SPG11 locus, as previously described (
<xref rid="awv320-B52" ref-type="bibr">
Orlacchio
<italic>et al.</italic>
, 2010
</xref>
). In the probands, all the coding exons of ALS5/SPG11/
<italic>KIAA1840</italic>
and at least 50 bp of flanking intronic sequence were PCR-amplified by primer pairs, as previously described (
<xref rid="awv320-B67" ref-type="bibr">
Stevanin
<italic>et al.</italic>
, 2007
<italic>a</italic></xref>
), and by Roche FastStartâ¢ PCR Master Mix polymerase. All the PCR-amplified products were purified using a Qiagen PCR purification kit. Purified products were sequenced with respective forward and reverse primers by an Applied Biosystems 3130 Genetic Analyzer. Sequence analysis was performed using SeqScape software (v2.6; Applied Biosystems). Large genomic rearrangements of ALS5/SPG11/
<italic>KIAA1840</italic>
gene were investigated by multiplex ligation-dependent probe amplification method with the P306-B1 SPG11 probe mix, containing probes for each of the 40
<italic>KIAA1840</italic>
exons. Data were collected and analysed with GeneScan software (v.3.1.2; Applied Biosystems). For each sample, peak areas were calculated and compared with three wild-type controls, using Coffalyser software (v.7.0; MRC Holland).
</p>
        <p>The segregation analysis within the family and the surveillance of mutations in the control population were performed using a PCR-restriction fragment length polymorphism method. Three hundred control chromosomes were obtained from healthy volunteers of mixed ethnic origins, including Caucasian, Brazilian and Japanese.</p>
        <p>
An
<italic>in silico</italic>
pathogenicity prediction tool (Mutation Taster,
<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org">http:www.mutationtaster.org</ext-link>
) was used to predict the effect of the novel mutations identified, as previously described (
<xref rid="awv320-B10" ref-type="bibr">
Carosi
<italic>et al.</italic>
, 2015
</xref>
).
</p>
        <p>
In all probands, we performed direct sequencing of all exons and flanking introns of CMT2A2/HMSN2A2/
<italic>MFN2</italic>
(OMIM: #609260;
<xref rid="awv320-B49" ref-type="bibr">
Nicholson
<italic>et al.</italic>
, 2008
</xref>
)
<italic>,</italic>
CMT2B1/
<italic>LMNA</italic>
(OMIM: #605588;
<xref rid="awv320-B18" ref-type="bibr">
De Sandre-Giovannoli
<italic>et al.</italic>
, 2002
</xref>
), CMT2B2/
<italic>MED25</italic>
(OMIM: #605589;
<xref rid="awv320-B41" ref-type="bibr">
Leal
<italic>et al.</italic>
, 2009
</xref>
), CMT2B5/
<italic>NEFL</italic>
(OMIM: #607734;
<xref rid="awv320-B76" ref-type="bibr">
Yum
<italic>et al.</italic>
, 2009
</xref>
), ARCMT2F/dHMN2B/
<italic>HSPB1</italic>
(OMIM: #608634;
<xref rid="awv320-B36" ref-type="bibr">
Houlden
<italic>et al.</italic>
, 2008
</xref>
), CMT2K/
<italic>GDAP1</italic>
(OMIM: #607831;
<xref rid="awv320-B14" ref-type="bibr">
Claramunt
<italic>et al.</italic>
, 2005
</xref>
), CMT2P/
<italic>LRSAM1</italic>
(OMIM: #614436;
<xref rid="awv320-B30" ref-type="bibr">
Guernsey
<italic>et al.</italic>
, 2010
</xref>
), CMT2R/
<italic>TRIM2</italic>
(OMIM: #615490;
<xref rid="awv320-B56" ref-type="bibr">
Pehlivan
<italic>et al.</italic>
, 2015
</xref>
), CMT2S/
<italic>IGHMBP2</italic>
(OMIM: #616155;
<xref rid="awv320-B15" ref-type="bibr">
Cottenie
<italic>et al.</italic>
, 2014
</xref>
), CMT2T/
<italic>HSJ1</italic>
(OMIM: #616233;
<xref rid="awv320-B27" ref-type="bibr">
Gess
<italic>et al.</italic>
, 2014
</xref>
), CMTRID/
<italic>COX6A1</italic>
(OMIM: #616039;
<xref rid="awv320-B69" ref-type="bibr">
Tamiya
<italic>et al.</italic>
, 2014
</xref>
), ARAN-NM/
<italic>HINT</italic>
(OMIM: #137200;
<xref rid="awv320-B78" ref-type="bibr">
ZimoÅ
<italic>et al.</italic>
, 2012
</xref>
), GAN/
<italic>GAN</italic>
(OMIM: #256850;
<xref rid="awv320-B7" ref-type="bibr">
Bomont
<italic>et al.</italic>
, 2000
</xref>
), SPG7/
<italic>PGN</italic>
(OMIM: #607259;
<xref rid="awv320-B11" ref-type="bibr">
Casari
<italic>et al.</italic>
, 1998
</xref>
), SPG15/
<italic>ZFYVE26</italic>
(OMIM: #270700;
<xref rid="awv320-B32" ref-type="bibr">
Hanein
<italic>et al.</italic>
, 2008
</xref>
), SPG21/
<italic>ACP33</italic>
(OMIM: #248900;
<xref rid="awv320-B65" ref-type="bibr">
Simpson
<italic>et al.</italic>
, 2003
</xref>
), SPG35/
<italic>FA2H</italic>
(OMIM: #612319;
<xref rid="awv320-B59" ref-type="bibr">
Pierson
<italic>et al.</italic>
, 2012
</xref>
), SPG46/
<italic>GBA2</italic>
(OMIM: #614409;
<xref rid="awv320-B31" ref-type="bibr">
Hammer
<italic>et al.</italic>
, 2013
</xref>
;
<xref rid="awv320-B45" ref-type="bibr">
Martin
<italic>et al.</italic>
, 2013
</xref>
), SPG55/
<italic>C12orf65</italic>
(OMIM: #615035;
<xref rid="awv320-B66" ref-type="bibr">
Spiegel
<italic>et al.</italic>
, 2014
</xref>
), SPG56/
<italic>CYP2U1</italic>
(OMIM: #610670;
<xref rid="awv320-B73" ref-type="bibr">
Tesson
<italic>et al.</italic>
, 2012
</xref>
), and
<italic>SLC12A6</italic>
(OMIM: #604878;
<xref rid="awv320-B37" ref-type="bibr">
Howard
<italic>et al.</italic>
, 2002
</xref>
). Direct sequencing of
<italic>POLG</italic>
(OMIM: #174763;
<xref rid="awv320-B75" ref-type="bibr">
Van Goethem
<italic>et al.</italic>
, 2001
</xref>
) and
<italic>TYMP</italic>
(OMIM: #131222;
<xref rid="awv320-B50" ref-type="bibr">
Nishino
<italic>et al.</italic>
, 2000
</xref>
) genes was also carried out to exclude mitochondrial disorders related to CMT2 (
<xref rid="awv320-B12" ref-type="bibr">
Cassereau
<italic>et al.</italic>
, 2014
</xref>
). Furthermore, linkage to chromosome 8q13-21.1 was performed to investigate autosomal recessive CMT2H, as previously reported (
<xref rid="awv320-B2" ref-type="bibr">
Barhoumi
<italic>et al.</italic>
, 2001
</xref>
).
</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Genetic findings</title>
        <p>
Linkage analysis in 28 unrelated pedigrees with ARCMT2 highlighted homozygous haplotypes with positive logarithm of odds score in all affected subjects from consanguineous parents of nine families (Families RM-501, RM-588, RM-603, RM-626, SP-012, SP-026, TOR-018, TOR-029 and TK-031), showing a cumulative two-point logarithm of odds score of 11.76 at the recombination fraction
<italic>Î¸</italic>
= 0.0 for marker D15S537 (
<xref ref-type="fig" rid="awv320-F1">Fig. 1</xref>
). The other ARCMT2 families showed heterozygous haplotypes and three of these kindred (Families RM-801, RM-888, and CAM-006) had positive logarithm of odds score in all affected individuals, showing a cumulative two-point logarithm of odds score of 6.29 at the recombination fraction
<italic>Î¸</italic>
= 0.0 for marker D15S537 (
<xref ref-type="fig" rid="awv320-F1">Fig. 1</xref>
). All other ARCMT2 pedigrees with heterozygous haplotypes had a negative or borderline significant cumulative logarithm of odds score by the genetic program HOMOG (
<xref rid="awv320-B53" ref-type="bibr">Ott, 1983</xref>
).
</p>
        <fig id="awv320-F1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>
<bold>Pedigrees and segregation chart of 12 ARCMT2 families linked to the ALS5/SPG11 locus</bold>
. Black solid symbols indicate affected individuals carrying ALS5/SPG11/
<italic>KIAA1840</italic>
mutations; white symbols represent unaffected subjects; square symbols are males, circles are females, and slashed symbols are deceased individuals. Individuals are reported as code numbers below the symbols. Probands are marked by arrows. Colour barcodes define the haplotypes created with markers D15S146, D15S537, D15S659, and D15S123, from
<italic>top</italic>
to
<italic>bottom</italic>
. Reconstructed genotypes are indicated by parentheses and question marks symbolize alleles that could not be reconstructed. The ALS5/SPG11/
<italic>KIAA1840</italic>
gene is placed between markers D15S537 and D15S659; key recombination events are observed between markers D15S659 and D15S123 in Patients 6013 (Family RM-626) and 835 (Family TOR-029), as well as between markers D15S146 and D15S537 in Patient 4294 (Family SP-012). * = sample subjects; m = mutation; + = wild-type.
</p>
          </caption>
          <graphic xlink:href="awv320f1p"/>
        </fig>
        <p>
We detected 15 different ALS5/SPG11/
<italic>KIAA1840</italic>
mutations in 29 affected individuals from 12 of 28 unrelated families with ARCMT2 (
<xref ref-type="table" rid="awv320-T1">Table 1</xref>
). Nine of these nucleotide changes were homozygous and six others, detected in the affected subjects of Families RM-801, RM-888 and CAM-006, were heterozygous compounds. All variants but one were truncating, including eight frameshift mutations, and six nonsense mutations. One nucleotide change (p.Arg945Gly) was a missense mutation. Variants segregated with the disease in all pedigrees and were absent in the panel of control chromosomes. Thirteen mutations had already been reported, while two (p.Gln198* and p.Pro2212Serfs*5) were novel and segregated with the disease (
<xref ref-type="table" rid="awv320-T1">Table 1</xref>
and
<xref ref-type="fig" rid="awv320-F2">Fig. 2</xref>
). Their pathogenic effect was predicted by bioinformatics analysis. In these families, the ALS5/SPG11/
<italic>KIAA1840</italic>
gene had no large deletions/duplications.
</p>
        <fig id="awv320-F2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>
<bold>
Pedigree charts, electropherograms and PCR-restriction fragment length polymorphism assays of families with novel ALS5/SPG11/
<italic>KIAA1840</italic>
mutations.
</bold>
(
<bold>A</bold>
) Pedigree charts RM-801 (
<bold>I</bold>
) and RM-888 (
<bold>II</bold>
). (
<bold>B</bold>
) Electropherogram of exon 3 of the ALS5/SPG11/
<italic>KIAA1840</italic>
gene in individuals of Family RM-801 (
<bold>I</bold>
), showing compound heterozygous status in the affected subjects (ID 7958, ID 7983, and ID 7995), as well as heterozygous status in the relatives (ID 7940, ID 7945, and ID 7970). (
<bold>II</bold>
) Electropherogram of exon 36 and exon 32 of the ALS5/SPG11/
<italic>KIAA1840</italic>
gene in individuals of Family RM-888 (
<bold>II</bold>
), displaying compound heterozygous status in the affected subjects (ID 8753, ID 8762, and ID 8780), and heterozygous status in the relatives (ID 8740, ID 8745, and ID 8752). (
<bold>C</bold>
) PCR-restriction fragment length polymorphism assays. After BsgI digestion, heterozygous individuals of Family RM-801 show three bands at 540, 351, and 189 base pairs (bp), while wild-type subjects display two bands at 351 and 189 bp (
<bold>I</bold>
). AseI digestion proves one band in wild-type components at 248 bp, as well as two bands at 273 and 248 bp in mutated individuals (
<bold>II</bold>
).
<italic>Cfr</italic>
10I digestion (c.6632dupG) leads to three bands at 268, 157, and 111 bp in heterozygous samples and one band at 268 bp (uncleaved) in wild-type components of Family RM-888 (
<bold>III</bold>
). Assay with enzyme Cac8I displays one band in wild-type individuals at 228 bp, as well as two bands at 260 and 228 bp in mutated subjects (
<bold>IV</bold>
). Wt = wild-type; Htz = heterozygous; Mut = mutated.
</p>
          </caption>
          <graphic xlink:href="awv320f2p"/>
        </fig>
        <table-wrap id="awv320-T1" orientation="portrait" position="float">
          <label>Table 1</label>
          <caption>
            <p>
Mutations identified in the ALS5/SPG11/
<italic>KIAA1840</italic>
gene
</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead align="left">
              <tr>
                <th colspan="1" rowspan="1">Family</th>
                <th colspan="1" rowspan="1">Location</th>
                <th colspan="1" rowspan="1">Mutation (cDNA)</th>
                <th colspan="1" rowspan="1">Effect on protein</th>
                <th colspan="1" rowspan="1">RFLP</th>
                <th colspan="1" rowspan="1">
Neuropathy
<sup>a</sup></th>
                <th colspan="1" rowspan="1">Reference study</th>
              </tr>
            </thead>
            <tbody align="left">
              <tr>
                <td colspan="1" rowspan="1">RM-501</td>
                <td colspan="1" rowspan="1">Exon 2</td>
                <td colspan="1" rowspan="1">c.398delG</td>
                <td colspan="1" rowspan="1">p.Cys133Leufs*22</td>
                <td colspan="1" rowspan="1">SfcI (loss)</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B55" ref-type="bibr">
Paisan-Ruiz
<italic>etÂ al</italic>
., 2008
</xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">RM-588</td>
                <td colspan="1" rowspan="1">Exon 15</td>
                <td colspan="1" rowspan="1">c.2678G&gt;A</td>
                <td colspan="1" rowspan="1">p.Trp893*</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">M</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B3" ref-type="bibr">
Bettencourt
<italic>etÂ al</italic>
., 2014
</xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">RM-603</td>
                <td colspan="1" rowspan="1">Exon 4</td>
                <td colspan="1" rowspan="1">c.704_705delAT</td>
                <td colspan="1" rowspan="1">p.His235Argfs*12</td>
                <td colspan="1" rowspan="1">BsiI (gain)</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B68" ref-type="bibr">
Stevanin
<italic>etÂ al</italic>
., 2007
<italic>b</italic></xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">RM-626</td>
                <td colspan="1" rowspan="1">Exon 1</td>
                <td colspan="1" rowspan="1">c.118C&gt;T</td>
                <td colspan="1" rowspan="1">p.Gln40*</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B67" ref-type="bibr">
Stevanin
<italic>etÂ al</italic>
., 2007
<italic>a</italic></xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="2">RM-801</td>
                <td colspan="1" rowspan="1">Exon 3</td>
                <td colspan="1" rowspan="1">c.592C&gt;T</td>
                <td colspan="1" rowspan="1">p.Gln198*</td>
                <td colspan="1" rowspan="1">BsgI (loss)</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">This study</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Exon 3</td>
                <td colspan="1" rowspan="1">c.529_533delATATT</td>
                <td colspan="1" rowspan="1">p.Ile177Serfs*2</td>
                <td colspan="1" rowspan="1">
AseI
<sup>b</sup>
(loss)
</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B67" ref-type="bibr">
Stevanin
<italic>etÂ al</italic>
., 2007
<italic>a</italic></xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="2">RM-888</td>
                <td colspan="1" rowspan="1">Exon 36</td>
                <td colspan="1" rowspan="1">c.6632dupG</td>
                <td colspan="1" rowspan="1">p.Pro2212fs*5</td>
                <td colspan="1" rowspan="1">Cfr10I (gain)</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">This study</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Exon 32</td>
                <td colspan="1" rowspan="1">c.6100C&gt;T</td>
                <td colspan="1" rowspan="1">p.Arg2034*</td>
                <td colspan="1" rowspan="1">
Cac8I
<sup>b</sup>
(loss)
</td>
                <td colspan="1" rowspan="1">
M/SM
<sup>c</sup></td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B67" ref-type="bibr">
Stevanin
<italic>etÂ al</italic>
., 2007
<italic>a</italic></xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">SP-012</td>
                <td colspan="1" rowspan="1">Exon 37</td>
                <td colspan="1" rowspan="1">c.6832_6833delAG</td>
                <td colspan="1" rowspan="1">p.Ser2278Leufs*61</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">M</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B68" ref-type="bibr">
Stevanin
<italic>etÂ al</italic>
., 2007
<italic>b</italic></xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">SP-026</td>
                <td colspan="1" rowspan="1">Exon 38</td>
                <td colspan="1" rowspan="1">c.6856C&gt;T</td>
                <td colspan="1" rowspan="1">p.Arg2286*</td>
                <td colspan="1" rowspan="1">MaeIII (gain)</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B20" ref-type="bibr">
Denora
<italic>etÂ al</italic>
., 2009
</xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">TOR-018</td>
                <td colspan="1" rowspan="1">Exon 15</td>
                <td colspan="1" rowspan="1">c.2697G&gt;A</td>
                <td colspan="1" rowspan="1">p.Trp899*</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B20" ref-type="bibr">
Denora
<italic>etÂ al</italic>
., 2009
</xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">TOR-029</td>
                <td colspan="1" rowspan="1">Exon 15</td>
                <td colspan="1" rowspan="1">c.2833A&gt;G </td>
                <td colspan="1" rowspan="1">p.Arg945Gly</td>
                <td colspan="1" rowspan="1">MscI (loss)</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B68" ref-type="bibr">
Stevanin
<italic>etÂ al</italic>
., 2007
<italic>b</italic></xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="2">CAM-006</td>
                <td colspan="1" rowspan="1">Exon 7</td>
                <td colspan="1" rowspan="1">c.1549_1550delCT</td>
                <td colspan="1" rowspan="1">p.Leu518Leufs*39</td>
                <td colspan="1" rowspan="1">AhdI (gain)</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B68" ref-type="bibr">
Stevanin
<italic>etÂ al</italic>
., 2007
<italic>b</italic></xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Exon 36</td>
                <td colspan="1" rowspan="1">c.6739_6742delGAGT</td>
                <td colspan="1" rowspan="1">p.Glu2247Leufs*14</td>
                <td colspan="1" rowspan="1">TfiI (gain)</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B68" ref-type="bibr">
Stevanin
<italic>etÂ al</italic>
., 2007
<italic>b</italic></xref>
</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">TK-031</td>
                <td colspan="1" rowspan="1">Exon 1</td>
                <td colspan="1" rowspan="1">c.165del19</td>
                <td colspan="1" rowspan="1">p.Ser56Alafs*7</td>
                <td colspan="1" rowspan="1">Cac8I (loss)</td>
                <td colspan="1" rowspan="1">SM</td>
                <td colspan="1" rowspan="1">
<xref rid="awv320-B57" ref-type="bibr">
Pensato
<italic>etÂ al</italic>
., 2014
</xref>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="awv320-TF1">
              <p>Gene nucleotide numbering was based on the reference sequence NM_025137.3, with the A of the ATG start codon as position 1.</p>
            </fn>
            <fn id="awv320-TF2">
              <p>delâ=âdeletion; fsâ=âframeshift; insâ=âinsertion; Mâ=âmotor; SMâ=âsensorimotor; RFLPâ=ârestriction fragment length polymorphism.</p>
            </fn>
            <fn id="awv320-TF20">
              <p>
<sup>a</sup>
Axonal peripheral neuropathy refers to previously reported features;
<bold><sup>b</sup></bold>
mismatch primer used;
<sup>c</sup>
axonal and demyelinating peripheral neuropathy.
</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>
Genetic analysis of the other candidate genes (CMT2A2/HMSN2A2/
<italic>MFN2</italic>
, CMT2B1/
<italic>LMNA</italic>
, CMT2B2/
<italic>MED25</italic>
, CMT2B5/
<italic>NEFL</italic>
, ARCMT2F/dHMN2B/
<italic>HSPB1</italic>
, CMT2K/
<italic>GDAP1</italic>
, CMT2P/
<italic>LRSAM1</italic>
, CMT2R/
<italic>TRIM2</italic>
, CMT2S/
<italic>IGHMBP2</italic>
, CMT2T/
<italic>HSJ1</italic>
, CMTRID/
<italic>COX6A1</italic>
, ARAN-NM/
<italic>HINT</italic>
, GAN/
<italic>GAN</italic>
, SPG7/
<italic>PGN</italic>
, SPG15/
<italic>ZFYVE26</italic>
, SPG21/
<italic>ACP33</italic>
, SPG35/
<italic>FA2H</italic>
, SPG46/
<italic>GBA2</italic>
, SPG56/
<italic>CYP2U1</italic>
, and
<italic>SLC12A6</italic>
) did not reveal any coding mutations in the unrelated 28 families with ARCMT2. Direct sequencing of
<italic>POLG</italic>
and
<italic>TYMP</italic>
genes excluded mitochondrial disorders related to CMT2. Linkage analysis showed no linkage to chromosome 8q13-21.1 in all families (cumulative logarithm of odds score was â2.11 for marker D15S537 at
<italic>Î¸</italic>
= 0.0).
</p>
      </sec>
      <sec>
        <title>
Clinical findings of the ALS5/SPG11/
<italic>KIAA1840</italic>
-related ARCMT2 families
</title>
        <p>
Among the 12 ALS5/SPG11/
<italic>KIAA1840</italic>
mutated pedigrees, nine showed consanguinity marriage (first-degree cousins) in their parents. Six families were from Italy, two from Brazil, one from England, and one from Japan. Moreover, two families were from Canada, one of which was an Iranian family who emigrated to Ontario (
<xref ref-type="fig" rid="awv320-F1">Fig. 1</xref>
).
</p>
        <p>
Affected subjects had a mainly distal, slowly progressive sensory and motor axonal neuropathy. The age at onset of the first motor symptoms in the 29 mutated ALS5/SPG11/
<italic>KIAA1840</italic>
patients oscillated from 4 to 35, with a mean of 11.4 Â± 5.9 years. The mean age at examination was 25.1 Â± 7.8 years (range 9â52).
</p>
        <p>
A wide variation of phenotypic expression was detected (
<xref ref-type="table" rid="awv320-T2">Table 2</xref>
). Asymmetrical onset in lower limbs was present in 12 patients. Distal lower limb weakness was found in all affected individuals; 16 patients showed muscular weakness in upper limbs too. Wasting was frequent in lower limb muscles distally (69%) and in intrinsic hand muscles (48%). Lower limb fasciculations were detected in eight patients. No patient showed pontobulbar signs, such as jaw spasticity, poor palatal elevation, increased facial reflexes, masseter, pterygoids, sternocleidomastoid, tongue muscle weakness, or muscle atrophy with fasciculations. Four patients had proximal lower limb weakness. Loss of pinprick and light touch sensation was common and involved lower limbs in most cases (86%).
</p>
        <table-wrap id="awv320-T2" orientation="portrait" position="float">
          <label>Table 2</label>
          <caption>
            <p>
Clinical features of 29 patients with ALS5/SPG11/
<italic>KIAA1840</italic>
mutations
</p>
          </caption>
          <table frame="hsides" rules="groups">
            <tbody align="left">
              <tr>
                <td colspan="1" rowspan="1">
Onset
<xref ref-type="table-fn" rid="awv320-TF4"><sup>a</sup></xref>
in the second decade of life
</td>
                <td colspan="1" rowspan="1">21 (72)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Disease duration &gt;10 years</td>
                <td colspan="1" rowspan="1">18 (62)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Males</td>
                <td colspan="1" rowspan="1">15 (52)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Females</td>
                <td colspan="1" rowspan="1">14 (48)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Muscle weakness</td>
                <td colspan="1" rowspan="1"/>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââDistal lower limbs</td>
                <td colspan="1" rowspan="1">29 (100)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââProximal lower limbs</td>
                <td colspan="1" rowspan="1">4 (14)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââDistal upper limbs</td>
                <td colspan="1" rowspan="1">16 (55)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââProximal upper limbs</td>
                <td colspan="1" rowspan="1">0 (0)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Muscle wasting</td>
                <td colspan="1" rowspan="1"/>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââDistal lower limbs</td>
                <td colspan="1" rowspan="1">20 (69)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââProximal lower limbs</td>
                <td colspan="1" rowspan="1">1 (3)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââHands</td>
                <td colspan="1" rowspan="1">14 (48)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Loss of pinprick and light touch in lower limbs</td>
                <td colspan="1" rowspan="1">25 (86)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Loss of proprioception in lower limbs</td>
                <td colspan="1" rowspan="1">15 (52)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Loss of pinprick and light touch in upper limbs</td>
                <td colspan="1" rowspan="1">8 (28)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Loss of proprioception in upper limbs</td>
                <td colspan="1" rowspan="1">0 (0)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Total absence of deep tendon reflexes</td>
                <td colspan="1" rowspan="1"/>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââLower limbs</td>
                <td colspan="1" rowspan="1">8 (28)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââUpper limbs</td>
                <td colspan="1" rowspan="1">2 (7)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Asymmetrical onset</td>
                <td colspan="1" rowspan="1">12 (41)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Positive Romberg test</td>
                <td colspan="1" rowspan="1">7 (24)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Gait impairment</td>
                <td colspan="1" rowspan="1">18 (62)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Babinski sign</td>
                <td colspan="1" rowspan="1">2 (7)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Postural tremor</td>
                <td colspan="1" rowspan="1">10 (34)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Wrist contracture</td>
                <td colspan="1" rowspan="1">3 (10)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Elbow contractures</td>
                <td colspan="1" rowspan="1">1 (3)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Ankle contracture</td>
                <td colspan="1" rowspan="1">14 (48)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Calf hypertrophy</td>
                <td colspan="1" rowspan="1">4 (14)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Foot deformities</td>
                <td colspan="1" rowspan="1">23 (79)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Fasciculations</td>
                <td colspan="1" rowspan="1"/>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââLower limbs</td>
                <td colspan="1" rowspan="1">8 (28)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">ââââUpper limbs</td>
                <td colspan="1" rowspan="1">1 (3)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Foot drop</td>
                <td colspan="1" rowspan="1">11 (38)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Hand deformities</td>
                <td colspan="1" rowspan="1">7 (24)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Kyphoscoliosis</td>
                <td colspan="1" rowspan="1">17 (59)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Mental retardation</td>
                <td colspan="1" rowspan="1">3 (10)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Thin corpus callosum</td>
                <td colspan="1" rowspan="1">3 (10)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Cerebellar signs</td>
                <td colspan="1" rowspan="1">0 (0)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Retinal disease</td>
                <td colspan="1" rowspan="1">0 (0)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Grey matter atrophy on brain MRI</td>
                <td colspan="1" rowspan="1">1 (3)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">White matter abnormalities on brain MRI</td>
                <td colspan="1" rowspan="1">0 (0)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Bladder disturbances</td>
                <td colspan="1" rowspan="1">9 (31)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Sexual dysfunctions</td>
                <td colspan="1" rowspan="1">7 (24)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">Spasticity</td>
                <td colspan="1" rowspan="1">0 (0)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">FDS 0-2</td>
                <td colspan="1" rowspan="1">14 (48)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">FDS 3-5</td>
                <td colspan="1" rowspan="1">13 (45)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">FDS 6-8</td>
                <td colspan="1" rowspan="1">2 (7)*</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">CMTNS mild</td>
                <td colspan="1" rowspan="1">9 (31)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">CMTNS moderate</td>
                <td colspan="1" rowspan="1">16 (55)</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">CMTNS severe</td>
                <td colspan="1" rowspan="1">4 (14)#</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="awv320-TF3">
              <p>
Values are
<italic>n</italic>
(%).
</p>
            </fn>
            <fn id="awv320-TF4">
              <p>
<sup>a</sup>
Age at onset was calculated as the time when motor symptoms appeared. FDS (Functional Disability Scale) from 0 to 8 as follows: 0 = normal; 1 = normal, but with cramps and fatigability; 2 = inability to run; 3 = walking difficult, but still possible unaided; 4 = able to walk with a cane; 5 = able to walk with crutches; 6 = able to walk with a walker; 7 = wheelchair bound; 8 = bedridden. CMTNS = Charcot-Marie-Tooth Neuropathy Score: mild (â¤10), moderate (11â20), and severe (&gt;20). *Ages at onset were 4 and 9 years;
<sup>#</sup>
ages at onset were 4, 8, 9, and 12 years.
</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>
The most frequent additional signs were foot deformities (79%), mainly
<italic>pes cavus</italic>
and kyphoscoliosis (59%). Hand deformities were present in seven patients with longer disease duration. Ankle contracture was present in 14 patients (48%) and tremor in 10 (34%). Bladder disturbances and sexual dysfunctions were detected in about one-third of the affected subjects. Babinskiâs sign was present bilaterally in two unrelated patients. No affected subject showed cerebellar signs or retinal disease.
</p>
        <p>
Brain MRI images were available for all mutated
<italic>KIAA1840</italic>
patients. Thin corpus callosum was evident in the three affected siblings of Family RM-801, with severe thinning of the anterior portion and mild thinning of the splenium (
<xref ref-type="fig" rid="awv320-F3">Fig. 3</xref>
A). These patients had low scores in the Wechsler Intelligence Scales for Children IV Intelligence Quotient (ID 7958: 51, ID 7983: 49, and ID 7995: 62; at 13, 11, and 9 years, respectively) with poor school performance and deficit in memory and calculation tests. Normal corpus callosum and no mental retardation or cognitive deficits were observed in the other ARCMT2
<italic>KIAA1840</italic>
-mutated subjects.
</p>
        <fig id="awv320-F3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>
<bold>Clinical features of Patients 7958 (Family RM-801) and 8780 (Family RM-888)</bold>
. (
<bold>A</bold>
) T
<sub>1</sub>
-weighted MRI showing thin corpus callosum in the proband of Family RM-801. (
<bold>B</bold>
)
<italic>Pes cavovarus</italic>
of the same patient. (
<bold>C</bold>
) Deformities and (
<bold>D</bold>
) global atrophy of hands in the proband of Family RM-888. (
<bold>E</bold>
) Atrophied legs with
<italic>pes cavus</italic>
of the same patient.
</p>
          </caption>
          <graphic xlink:href="awv320f3p"/>
        </fig>
        <p>Haematological and biochemical profiles, including serum creatine kinase, were unremarkable in all subjects. Lysosomal enzyme assay of peripheral blood leucocytes revealed that both Î²-hexosaminidase A and B isoenzymes were present at normal levels. Vitamins were within normal range. The CSF analysis was within normal range in the five patients analysed.</p>
        <p>
The disease was slowly progressive and most patients (86%) expressed mild-to-moderate phenotypes (CharcotâMarieâTooth neuropathy score &lt; 20); only two patients, one of which was wheelchair bound, reached Functional Disability Scale scores &gt; 5 (
<xref ref-type="table" rid="awv320-T2">Table 2</xref>
).
</p>
        <p>
Motor and sensory conduction studies showed motor and sensory axonal neuropathy, more prominent in lower limbs, with low amplitudes of compound motor and sensory nerve action potentials. Motor and sensory nerve conduction velocities were normal or slightly reduced, according to the secondary demyelinating processes. All motor nerve conduction velocities of median nerves were &gt;38 m/s, differentiating CMT2 from CMT1. In 29 affected individuals, EMG of the tibialis anterior muscle detected predominant findings of chronic denervation/reinnervation (motor unit action potentials with long duration and large amplitude, or polyphasic, along with single or mixed interference patterns), and/or active denervation signs (fibrillation potentials, positive sharp waves, as well as fasciculation potentials). In 11 affected subjects, EMG of the abductor pollicis brevis muscle showed similar neurophysiological characteristics (
<xref ref-type="table" rid="awv320-T3">Table 3</xref>
).
</p>
        <table-wrap id="awv320-T3" orientation="portrait" position="float">
          <label>Table 3</label>
          <caption>
            <p>
Electroneurography and EMG characteristics in the 29 ALS5/SPG11/
<italic>KIAA1840</italic>
âmutated individuals
</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead align="left">
              <tr>
                <th colspan="1" rowspan="1"/>
                <th colspan="1" rowspan="1">MeanâÂ±âSD</th>
                <th colspan="1" rowspan="1">Range</th>
                <th colspan="1" rowspan="1">
Reference lower value
<sup>a</sup></th>
                <th colspan="1" rowspan="1">UR (subjects)</th>
                <th colspan="1" rowspan="1">
Pathological (subjects)
<sup>b</sup></th>
                <th colspan="1" rowspan="1">Chronic denervation</th>
                <th colspan="1" rowspan="1">Active denervation</th>
              </tr>
            </thead>
            <tbody align="left">
              <tr>
                <td colspan="8" rowspan="1">Median nerve</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">CMAP (mV)</td>
                <td colspan="1" rowspan="1">3.6âÂ±â2.4</td>
                <td colspan="1" rowspan="1">0.1â9.2</td>
                <td colspan="1" rowspan="1">5</td>
                <td colspan="1" rowspan="1">5</td>
                <td colspan="1" rowspan="1">15</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">
SNAP (ÂµV)
<sup>c</sup></td>
                <td colspan="1" rowspan="1">6.8âÂ±â5.3</td>
                <td colspan="1" rowspan="1">0.4â21.7</td>
                <td colspan="1" rowspan="1">9</td>
                <td colspan="1" rowspan="1">6</td>
                <td colspan="1" rowspan="1">16</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">MNCV (m/s)</td>
                <td colspan="1" rowspan="1">48.1âÂ±â7.5</td>
                <td colspan="1" rowspan="1">39â67</td>
                <td colspan="1" rowspan="1">50</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">12</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">SNCV (m/s)</td>
                <td colspan="1" rowspan="1">51.1âÂ±â8.2</td>
                <td colspan="1" rowspan="1">35â64</td>
                <td colspan="1" rowspan="1">54</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">13</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">Peroneal nerve</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">CMAP (mV)</td>
                <td colspan="1" rowspan="1">2.1âÂ±â3.8</td>
                <td colspan="1" rowspan="1">0.1â11.8</td>
                <td colspan="1" rowspan="1">3</td>
                <td colspan="1" rowspan="1">13</td>
                <td colspan="1" rowspan="1">26</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">MNCV (m/s)</td>
                <td colspan="1" rowspan="1">38.3âÂ±â5.1</td>
                <td colspan="1" rowspan="1">31â44</td>
                <td colspan="1" rowspan="1">42</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">20</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">Tibial nerve</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">CMAP (mV)</td>
                <td colspan="1" rowspan="1">2.4âÂ±â3.9</td>
                <td colspan="1" rowspan="1">0.1â16.5</td>
                <td colspan="1" rowspan="1">4</td>
                <td colspan="1" rowspan="1">14</td>
                <td colspan="1" rowspan="1">27</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">MNCV (m/s)</td>
                <td colspan="1" rowspan="1">38.1âÂ±â4.8</td>
                <td colspan="1" rowspan="1">32â46</td>
                <td colspan="1" rowspan="1">42</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">21</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">Sural nerve</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">SNAP (ÂµV)</td>
                <td colspan="1" rowspan="1">2.3âÂ±â1.5</td>
                <td colspan="1" rowspan="1">0.3â3.8</td>
                <td colspan="1" rowspan="1">*</td>
                <td colspan="1" rowspan="1">16</td>
                <td colspan="1" rowspan="1">29</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">SNCV (m/s)</td>
                <td colspan="1" rowspan="1">37.3âÂ±â5.2</td>
                <td colspan="1" rowspan="1">31â47</td>
                <td colspan="1" rowspan="1">42</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">22</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">TA muscle</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">29</td>
                <td colspan="1" rowspan="1">23</td>
                <td colspan="1" rowspan="1">8</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1">APB muscle</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">â</td>
                <td colspan="1" rowspan="1">11</td>
                <td colspan="1" rowspan="1">9</td>
                <td colspan="1" rowspan="1">3</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="awv320-TF5">
              <p>
APBâ=âabductor pollicis brevis; CMAPâ=âcompound nervous motor action potential (amplitude); MNCVâ=âmotor nerve conduction velocity; SDâ=âstandard deviation; SNAPâ=âsensory nerve action potential (amplitude); SNCVâ=âsensory nerve conduction velocity; TAâ=âtibialis anterior; URâ=âunrecordable (action potentials).
<bold><sup>a</sup></bold>
Reference lower value is the lower limit assessed by our laboratories;
<sup>b</sup>
The âPathologicalâ column includes nonârecordable items;
<sup>c</sup>
Orthodromic evaluation. *SNAP reference lower value of sural nerve is calculated as: 11.34âââ(0.092âÃâage in years) â 5.04âÂµV (
<xref rid="awv320-B4" ref-type="bibr">Bienfait, 2007</xref>
).
</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>
Neuropathological analyses of the sural nerve biopsies were performed in 17 mutated patients and showed loss of myelinated fibres (
<xref ref-type="fig" rid="awv320-F4">Fig. 4</xref>
A), mainly in fibres of large calibre, in line with the diagnosis of CMT2.
</p>
        <fig id="awv320-F4" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>
<bold>Sural nerve biopsy of Patient 7958 (Family RM-801).</bold>
(
<bold>A</bold>
) Transverse cryostat section showing a nerve fascicle with medium grade myelinated fibre loss. Modified Gomori Trichrome Stain, Ã80. (
<bold>BâD</bold>
) Transmission electron micrographs showing: (
<bold>B</bold>
) an unmyelinated fibre displaying intra-axonal aggregates, seemingly composed by neurotubules and neurofilaments, Ã85 000; (
<bold>C</bold>
) flattened Schwann cell processes indicating unmyelinated axon loss, Ã30 000; (
<bold>D</bold>
) a rudimentary onion bulb surrounding an apparently intact myelinated fibre, possibly indicating secondary Schwann cell pathology, Ã7000.
</p>
          </caption>
          <graphic xlink:href="awv320f4p"/>
        </fig>
        <p>
See the online
<xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>
for indicative case reports of patients with novel ALS5/SPG11/
<italic>KIAA1840</italic>
mutations.
</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>
The ALS5/SPG11/
<italic>KIAA1840</italic>
gene was analysed in ARCMT2 patients from 28 unrelated pedigrees and a high frequency of pathogenic mutations, two of which were novel, was found in 12 families (43%), appearing to be a significant cause of ARCMT2. Our study showed novel genotypeâphenotype correlation, which further broadens the clinical spectrum associated with ALS5/SPG11/
<italic>KIAA1840</italic>
mutations (
<xref ref-type="fig" rid="awv320-F5">Fig. 5</xref>
). Therefore, genetic screening of the ALS5/SPG11/
<italic>KIAA1840</italic>
gene should be considered not only in patients with ARHSP with thin corpus callosum and in affected individuals with ARJALS, but also in affected subjects with ARCMT2. Due to the complexity and heterogeneity of these neurodegenerative diseases, next-generation sequencing techniques are the most effective diagnostic tool to identify the genetic cause in patients with myelopathy or neuropathy, either by targeted sequencing panel approach or by whole-genome sequencing.
</p>
      <fig id="awv320-F5" orientation="portrait" position="float">
        <label>Figure 5</label>
        <caption>
          <p>
<bold>Schematic representation of the ALS5/SPG11 protein and position of previously reported (black) and novel (red) mutations, stratified by distinctive phenotypes</bold>
. Specific mutations for clinical heterogeneity are represented. Putative functional domains are depicted as rectangles, and their positions within the amino acid sequence are indicated: the transmembrane domain (blue box; positions, 163â194, 200â240, 1239â1267, and 1471â1493), glycosyl hydroxylase F1 signature (pink box; position, 482â490), leucine zipper (green box; position, 611â632), coil-coil domain (grey box; position, 1556â1590), and Myb domain (red box; position 1766â1774). Arrows indicate truncating mutations; dotted arrows indicate missense mutations. Aa = amino acids.
<sup>a</sup>
This study;
<sup>b</sup><xref rid="awv320-B52" ref-type="bibr">
Orlacchio
<italic>et al.</italic>
, 2010
</xref>
;
<sup>c</sup><xref rid="awv320-B79" ref-type="bibr">
Daoud
<italic>et al.</italic>
, 2012
</xref>
;
<sup>d</sup><xref rid="awv320-B34" ref-type="bibr">
Hehr
<italic>et al.</italic>
, 2007
</xref>
;
<sup>e</sup><xref rid="awv320-B57" ref-type="bibr">
Pensato
<italic>et al.</italic>
, 2014
</xref>
;
<sup>f</sup><xref rid="awv320-B55" ref-type="bibr">
Paisan-Ruiz
<italic>et al.</italic>
, 2008
</xref>
;
<sup>g</sup><xref rid="awv320-B67" ref-type="bibr">
Stevanin
<italic>et al.</italic>
, 2007
<italic>a</italic></xref>
;
<sup>h</sup><xref rid="awv320-B68" ref-type="bibr">
Stevanin
<italic>et al.</italic>
, 2007
<italic>b</italic></xref>
;
<sup>i</sup><xref rid="awv320-B60" ref-type="bibr">
Pippucci
<italic>et al.</italic>
, 2009
</xref>
;
<sup>j</sup><xref rid="awv320-B3" ref-type="bibr">
Bettencourt
<italic>et al.</italic>
, 2014
</xref>
;
<sup>k</sup><xref rid="awv320-B20" ref-type="bibr">
Denora
<italic>et al.</italic>
, 2009
</xref>
;
<sup>l</sup><xref rid="awv320-B42" ref-type="bibr">
Lee
<italic>et al.</italic>
, 2008
</xref>
;
<sup>m</sup><xref rid="awv320-B19" ref-type="bibr">
Del Bo
<italic>et al.</italic>
, 2007
</xref>
;
<sup>n</sup><xref rid="awv320-B61" ref-type="bibr">
Querin
<italic>et al.</italic>
, 2014
</xref>
.
</p>
        </caption>
        <graphic xlink:href="awv320f5p"/>
      </fig>
      <p>
This clinicalâgenetic entity shows a worldwide distribution, since the pedigrees carrying mutations in ALS5/SPG11/
<italic>KIAA1840</italic>
were from Italy, Brazil, Canada, England, Iran, and Japan. The variants are scattered throughout the entire amino acid sequence, without evidence of âhot spotsâ, and 93% were truncating mutations. This finding is consistent with previous studies describing mostly mutations leading to the truncation of the ALS5/SPG11 protein and consequent loss of function mechanism (
<xref rid="awv320-B57" ref-type="bibr">
Pensato
<italic>et al.</italic>
, 2014
</xref>
). Furthermore, a probable mechanism of nonsense-mediated mRNA decay might also be hypothesized (
<xref rid="awv320-B55" ref-type="bibr">
Paisan-Ruiz
<italic>et al.</italic>
, 2008
</xref>
).
</p>
      <p>
The two unrelated ARCMT2 patients with bilateral Babinskiâs sign further enlarge the clinical spectrum of the disorder, showing that
<italic>KIAA1840</italic>
-related diseases might be clinically suspected if neuropathy is present in addition to upper motor neuron signs or symptoms, e.g. deep tendon reflexes are symmetrically diminished in the lower extremities with bilateral positive Babinskiâs sign. Moreover, the impairment of higher mental functions impairment and brain alterations at MRI in three affected siblings of one ARCMT2 family should be noted. Indeed, the presence of clinical signs of leukoencephalopathy, as well as white matter alterations at brain MRI, has been previously reported in demyelinating, axonal, and intermediate forms of the disorder (
<xref rid="awv320-B26" ref-type="bibr">
Genari
<italic>et al.</italic>
, 2011
</xref>
;
<xref rid="awv320-B62" ref-type="bibr">
Reyes-Marin
<italic>et al.</italic>
, 2011
</xref>
;
<xref rid="awv320-B63" ref-type="bibr">
Sagnelli
<italic>et al.</italic>
, 2014
</xref>
). Therefore, we believe that brain MRI and neuropsychological testing are useful tools in the clinical work-up of patients with CharcotâMarieâTooth disease. To our knowledge, this is the first report of ALS5/SPG11/
<italic>KIAA1840</italic>
mutations in subjects with ARCMT2 and all of our families can be classified as CMT2X, according to the classification of the CharcotâMarieâTooth disease currently used in OMIM (
<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim">http://www.ncbi.nlm.nih.gov/omim</ext-link>
).
</p>
      <p>
The disease has a slow progression and affected subjects with earlier onset show a more severe phenotype compared to those with late onset. Overall, the age at onset is the second decade of life, in line with both ARCMT2 and ARHSP (
<xref rid="awv320-B70" ref-type="bibr">
Tazir
<italic>et al.</italic>
, 2013
</xref>
;
<xref rid="awv320-B44" ref-type="bibr">
Lo Giudice
<italic>et al.</italic>
, 2014
</xref>
). Clinical heterogeneity is well documented in ALS5/SPG11/
<italic>KIAA1840</italic>
mutations causing ARHSP, ranging from the most frequent association of thin corpus callosum, white matter alterations, mental retardation, cerebellar signs, and axonal peripheral neuropathy, to less common clinical findings, such as seizures, abnormal eye signs, maculopathy, amyotrophy, and parkinsonism (
<xref rid="awv320-B72" ref-type="bibr">
Tessa
<italic>et al.</italic>
, 2014
</xref>
). In addition, ALS5/SPG11/
<italic>KIAA1840</italic>
mutations have been often found in patients with ARJALS (
<xref rid="awv320-B52" ref-type="bibr">
Orlacchio
<italic>et al.</italic>
, 2010
</xref>
). Interestingly, no specific differences in the type of variants, or position within the primary amino acid sequence, were observed. Even identical mutations causing different phenotypes were found (
<xref ref-type="fig" rid="awv320-F5">Fig. 5</xref>
), confirming that variants at the same locus can lead to distinct phenotypes (
<xref rid="awv320-B33" ref-type="bibr">Hegele, 2005</xref>
). This aspect is not uncommon in monogenic diseases and demonstrates how genotypeâphenotype associations can be often unpredictable.
</p>
      <p>
The complexity of a correct clinical classification of motor neuron diseases linked to spatacsin is further increased by the presence of ALS5/SPG11/
<italic>KIAA1840</italic>
mutations in patients with an overlapping phenotype, exhibiting features of amyotrophic lateral sclerosis as well as spastic paraplegia, as described by
<xref rid="awv320-B61" ref-type="bibr">
Querin
<italic>et al.</italic>
(2014)
</xref>
.
</p>
      <p>
As previously hypothesized, the ALS5/SPG11/
<italic>KIAA1840</italic>
phenotype results from the combined degeneration of central and peripheral axons (
<xref rid="awv320-B34" ref-type="bibr">
Hehr
<italic>et al.</italic>
, 2007
</xref>
). In particular, peripheral neuropathy might affect both sensory and motor fibres and might lead to pure distal amyotrophy, as well as to CMT2. The roles of spatacsin in the cellular pathway of axonal maintenance, including cargo trafficking, is becoming clearer: it is located in axons and dendrites, co-localized with cytoskeletal and synaptic vesicles, and it is present in synaptosomes (
<xref rid="awv320-B13" ref-type="bibr">
ChiurchiÃ¹
<italic>et al.</italic>
, 2014
</xref>
;
<xref rid="awv320-B58" ref-type="bibr">
PÃ©rez-BrangulÃ­
<italic>et al.</italic>
, 2014
</xref>
). Other forms of hereditary spastic paraplegia linked to proteins involved in axon maintenance, such as kinesin SPG10/
<italic>KIF5A</italic>
and SPG17/
<italic>BSCL2</italic>
, are known to be allelic to CMT2 (
<xref rid="awv320-B28" ref-type="bibr">
Goizet
<italic>et al.</italic>
, 2009
</xref>
;
<xref rid="awv320-B38" ref-type="bibr">Ito and Suzuki, 2009</xref>
;
<xref rid="awv320-B17" ref-type="bibr">
Crimella
<italic>et al.</italic>
, 2012
</xref>
;
<xref rid="awv320-B74" ref-type="bibr">
Timmerman
<italic>et al.</italic>
, 2013
</xref>
). Furthermore, mutations in SPG4/
<italic>SPAST</italic>
, SPG3A
<italic>/ATL1</italic>
, SPG17/
<italic>BSCL2</italic>
, as well as SPG43/
<italic>C19orf12</italic>
might cause spastic paraplegia and axonal peripheral neuropathy with atrophy of small hand muscles (Silver syndrome) (
<xref rid="awv320-B77" ref-type="bibr">
Windpassinger
<italic>et al.</italic>
, 2004
</xref>
;
<xref rid="awv320-B51" ref-type="bibr">
Orlacchio
<italic>et al.</italic>
, 2008
</xref>
;
<xref rid="awv320-B25" ref-type="bibr">
Fusco
<italic>et al.</italic>
, 2010
</xref>
;
<xref rid="awv320-B40" ref-type="bibr">
LandourÃ©
<italic>et al.</italic>
, 2013
</xref>
). Besides, mutations in
<italic>ATL1</italic>
, whose protein is implicated in neurite outgrowth, intracellular membrane trafficking, and axon elongation during neuronal development (
<xref rid="awv320-B8" ref-type="bibr">Byrnes and Sondermann, 2011</xref>
), might cause hereditary sensory neuropathy type I (HSN-I) with or without pyramidal tract features (
<xref rid="awv320-B29" ref-type="bibr">
Guelly
<italic>et al.</italic>
, 2011
</xref>
;
<xref rid="awv320-B43" ref-type="bibr">
Leonardis
<italic>et al.</italic>
, 2012
</xref>
).
</p>
      <p>
Remarkably, the previously reported mutations in ALS5/SPG11/
<italic>KIAA1840</italic>
were often associated with ARHSP complicated by axonal peripheral neuropathy, mainly motor, but also sensory (
<xref ref-type="table" rid="awv320-T1">Table 1</xref>
). In
<italic>KIAA1840</italic>
mutations, a preferential involvement of the CNS or the peripheral nervous system may be due to different causes. First of all, the bloodânerve barrier might influence protein expression in peripheral axons, as well as the bloodâbrain barrier in central axons. Moreover, ALS5/SPG11/
<italic>KIAA1840</italic>
knockdown in Zebrafish (
<italic>Danio rerio</italic>
) reveals a compromised outgrowth of spinal motor axons, thus indicating that spatacsin is involved in the formation of neuromuscular junctions during development (
<xref rid="awv320-B46" ref-type="bibr">
Martin
<italic>et al.</italic>
, 2012
</xref>
). The association in synaptosomes of spatacsin with spastizin (SPG15/
<italic>ZFYVE26</italic>
) and with the adaptor protein complex 5 (SPG48/
<italic>KIAA0415</italic>
) (
<xref rid="awv320-B35" ref-type="bibr">
Hirst
<italic>et al.</italic>
, 2013
</xref>
) suggests that the loss of function of spatacsin could not be the only mechanism for axonal dysfunction in ALS5/SPG11/
<italic>KIAA1840</italic>
-mutated patients. Indeed, it may be hypothesized that a variable phenotypic expression of
<italic>KIAA1840</italic>
mutations results from the interaction of gene modifier factors. Further studies are necessary to clarify whether allelic heterogeneity depends on environmental or other genetic/epigenetic factors. In conclusion, the presence of common molecular, pathological, and genetic features in
<italic>KIAA1840</italic>
-related diseases, suggests that the different phenotypes of axonal degeneration induced by ALS5/SPG11/
<italic>KIAA1840</italic>
mutations may be targeted by common therapeutic strategies.
</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="sup1">
        <label>Supplementary Data</label>
        <media xlink:href="awv320_supplementary_data.zip">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>
We thank the patients and their family members for taking part in this study. We thank Michela Renna (MA) for her language advice and assistance, Martina Di Lullo (BSc) and Valerio Battisti (BSc) for the technical support, and the members of our laboratories for the stimulating discussions and helpful comments on this manuscript. We are extremely grateful to the
<italic>Genetic Bank</italic>
of the
<italic>Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia</italic>
, Rome, Italy (
<ext-link ext-link-type="uri" xlink:href="http://www.hsantalucia.it/neurogen/index_en.htm">http://www.hsantalucia.it/neurogen/index_en.htm</ext-link>
) for the service provided.
</p>
    </ack>
    <sec>
      <title>Funding</title>
      <p>
This work was supported by the Italian
<italic>Ministero della Salute</italic>
(Grant no. GR09.109 to A.O.), the
<italic>Comitato Telethon Fondazione Onlus</italic>
, Italy (Grant no. GGP10121 to A.O.), the
<italic>UniversitÃ  di Roma âTor Vergataâ</italic>
, Rome, Italy (Grant no. E82I15000190005 to A.O.), the
<italic>Rotary Club Sanluri Medio Campidano</italic>
, Sanluri (VS), Italy (Grant
<italic>Noi per Voi</italic>
to A.O.), the Japan Society for the Promotion of Science (JSPS KAKENHI Grant no. 26461294 to T.K.), the Ministry of Health, Labour, and Welfare of Japan (Grant for research on rare and intractable diseases and establishment of novel treatments for amyotrophic lateral sclerosis to T.K.), and the Brain Science Foundation, Japan (Grant to T.K.).
</p>
    </sec>
    <sec sec-type="materials">
      <title>Supplementary material</title>
      <p>
<xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>
is available at
<italic>Brain</italic>
online.
</p>
    </sec>
    <glossary>
      <def-list>
        <title>Abbreviations</title>
        <def-item>
          <term id="G1">ARCMT2</term>
          <def>
            <p>autosomal recessive CharcotâMarieâTooth disease type 2</p>
          </def>
        </def-item>
        <def-item>
          <term id="G2">ARHSP</term>
          <def>
            <p>autosomal recessive hereditary spastic paraplegia</p>
          </def>
        </def-item>
        <def-item>
          <term id="G3">CMT</term>
          <def>
            <p>CharcotâMarieâTooth</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <title>References</title>
      <ref id="awv320-B1">
        <mixed-citation publication-type="book">
<collab>American Psychiatric Association</collab>
.
<article-title>Diagnotic and statistical manual of mental disorders</article-title>
. 5th edn.
<publisher-loc>Arlington, VA</publisher-loc>
:
<publisher-name>American Psychiatric Association</publisher-name>
;
<comment>2013. </comment><pub-id pub-id-type="doi">10.1176/appi.books.9780890425596</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B2">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barhoumi</surname><given-names>C</given-names></name><name><surname>Amouri</surname><given-names>R</given-names></name><name><surname>Ben Hamida</surname><given-names>C</given-names></name><name><surname>Ben Hamida</surname><given-names>M</given-names></name><name><surname>Machghoul</surname><given-names>S</given-names></name><name><surname>Gueddiche</surname><given-names>M</given-names></name><etal/></person-group>
.
<article-title>Linkage of a new locus for autosomal recessive axonal form of Charcot-Marie-Tooth disease to chromosome 8q21.3</article-title>
.
<source>Neuromuscul Disord</source><year>2001</year>
;
<volume>11</volume>
:
<fpage>27</fpage>
â
<lpage>34</lpage>
.
<pub-id pub-id-type="pmid">11166163</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B3">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bettencourt</surname><given-names>C</given-names></name><name><surname>LÃ³pez-SendÃ³n</surname><given-names>JL</given-names></name><name><surname>GarcÃ­a-Caldentey</surname><given-names>J</given-names></name><name><surname>Rizzu</surname><given-names>P</given-names></name><name><surname>Bakker</surname><given-names>IM</given-names></name><name><surname>Shomroni</surname><given-names>O</given-names></name><etal/></person-group>
.
<article-title>Exome sequencing is a useful diagnostic tool for complicated forms of hereditary spastic paraplegia</article-title>
.
<source>Clin Genet</source><year>2014</year>
;
<volume>85</volume>
:
<fpage>154</fpage>
â
<lpage>8</lpage>
.
<pub-id pub-id-type="pmid">23438842</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B4">
        <mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bienfait</surname><given-names>HME</given-names></name></person-group>
.
<article-title>Axonal phenotypes in Charcot-Marie-Tooth disease</article-title>
.
<publisher-loc>Amsterdam, The Netherlands</publisher-loc>
:
<publisher-name>Faculty of Medicine, University of Amsterdam (AMC-UvA)</publisher-name>
;
<year>2007</year>
.
<comment><ext-link ext-link-type="uri" xlink:href="http://dare.uva.nl/document/2/47043">http://dare.uva.nl/document/2/47043</ext-link></comment></mixed-citation>
      </ref>
      <ref id="awv320-B5">
        <mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bird</surname><given-names>DT</given-names></name></person-group>
.
<article-title>GeneReviews [Internet]</article-title>
In:
<person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>RA</given-names></name><name><surname>Adam</surname><given-names>MP</given-names></name><name><surname>Ardinger</surname><given-names>HH</given-names></name><name><surname>Bird</surname><given-names>DT</given-names></name><name><surname>Dolan</surname><given-names>CR</given-names></name><name><surname>Fong</surname><given-names>CT</given-names></name><etal/></person-group>
., editors.
<source>Charcot-Marie-Tooth neuropathy type 2</source>
.
<publisher-loc>Seattle, WA</publisher-loc>
:
<publisher-name>University of Washington, Seattle</publisher-name>
;
<year>1993-2015</year>
.
<comment><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK1285/">http://www.ncbi.nlm.nih.gov/books/NBK1285/</ext-link></comment></mixed-citation>
      </ref>
      <ref id="awv320-B6">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Birouk</surname><given-names>N</given-names></name><name><surname>Gouider</surname><given-names>R</given-names></name><name><surname>Le Guern</surname><given-names>E</given-names></name><name><surname>Gugenheim</surname><given-names>M</given-names></name><name><surname>Tardieu</surname><given-names>S</given-names></name><name><surname>Maisonobe</surname><given-names>T</given-names></name><etal/></person-group>
.
<article-title>Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases</article-title>
.
<source>Brain</source><year>1997</year>
;
<volume>120</volume>
:
<fpage>813</fpage>
â
<lpage>23</lpage>
.
<pub-id pub-id-type="pmid">9183252</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B7">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bomont</surname><given-names>P</given-names></name><name><surname>Cavalier</surname><given-names>L</given-names></name><name><surname>Blondeau</surname><given-names>F</given-names></name><name><surname>Ben Hamida</surname><given-names>C</given-names></name><name><surname>Belal</surname><given-names>S</given-names></name><name><surname>Tazir</surname><given-names>M</given-names></name><etal/></person-group>
.
<article-title>The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy</article-title>
.
<source>Nat Genet</source><year>2000</year>
;
<volume>26</volume>
:
<fpage>370</fpage>
â
<lpage>4</lpage>
.
<pub-id pub-id-type="pmid">11062483</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B8">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Byrnes</surname><given-names>LJ</given-names></name><name><surname>Sondermann</surname><given-names>H</given-names></name></person-group>
.
<article-title>Structural basis for the nucleotide-dependent dimerization of the large G protein atlastin-1/SPG3A</article-title>
.
<source>Proc Natl Acad Sci USA</source><year>2011</year>
;
<volume>108</volume>
:
<fpage>2216</fpage>
â
<lpage>21</lpage>
.
<pub-id pub-id-type="pmid">21220294</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B9">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carlesimo</surname><given-names>GA</given-names></name><name><surname>Caltagirone</surname><given-names>C</given-names></name><name><surname>Gainotti</surname><given-names>G</given-names></name></person-group>
.
<article-title>The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the mental deterioration battery</article-title>
.
<source>Eur Neurol</source><year>1996</year>
;
<volume>36</volume>
:
<fpage>378</fpage>
â
<lpage>84</lpage>
.
<pub-id pub-id-type="pmid">8954307</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B10">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carosi</surname><given-names>L</given-names></name><name><surname>Lo Giudice</surname><given-names>T</given-names></name><name><surname>Di Lullo</surname><given-names>M</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>Babalini</surname><given-names>C</given-names></name><name><surname>Gaudiello</surname><given-names>F</given-names></name><etal/></person-group>
.
<article-title>Hereditary spastic paraplegia: a novel mutation and expansion of the phenotype variability in SPG10</article-title>
.
<source>J Neurol Neurosurg Psychiatry</source><year>2015</year>
;
<volume>86</volume>
:
<fpage>702</fpage>
â
<lpage>4</lpage>
.
<pub-id pub-id-type="pmid">25352184</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B11">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Casari</surname><given-names>G</given-names></name><name><surname>De Fusco</surname><given-names>M</given-names></name><name><surname>Ciarmatori</surname><given-names>S</given-names></name><name><surname>Zeviani</surname><given-names>M</given-names></name><name><surname>Mora</surname><given-names>M</given-names></name><name><surname>Fernandez</surname><given-names>P</given-names></name><etal/></person-group>
.
<article-title>Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease</article-title>
.
<source>Cell</source><year>1998</year>
;
<volume>93</volume>
:
<fpage>973</fpage>
â
<lpage>83</lpage>
.
<pub-id pub-id-type="pmid">9635427</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B12">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cassereau</surname><given-names>J</given-names></name><name><surname>Codron</surname><given-names>P</given-names></name><name><surname>Funalot</surname><given-names>B</given-names></name></person-group>
.
<article-title>Inherited peripheral neuropathies due to mitochondrial disorders</article-title>
.
<source>Rev Neurol (Paris)</source><year>2014</year>
;
<volume>170</volume>
:
<fpage>366</fpage>
â
<lpage>74</lpage>
.
<pub-id pub-id-type="pmid">24768438</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B13">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>ChiurchiÃ¹</surname><given-names>V</given-names></name><name><surname>Maccarrone</surname><given-names>M</given-names></name><name><surname>Orlacchio</surname><given-names>A</given-names></name></person-group>
.
<article-title>The role of reticulons in neurodegenerative diseases</article-title>
.
<source>Neuromolecular Med [Review]</source><year>2014</year>
;
<volume>16</volume>
:
<fpage>3</fpage>
â
<lpage>15</lpage>
.
</mixed-citation>
      </ref>
      <ref id="awv320-B14">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Claramunt</surname><given-names>R</given-names></name><name><surname>Pedrola</surname><given-names>L</given-names></name><name><surname>Sevilla</surname><given-names>T</given-names></name><name><surname>LÃ³pez de Munain</surname><given-names>A</given-names></name><name><surname>Berciano</surname><given-names>J</given-names></name><name><surname>Cuesta</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect</article-title>
.
<source>J Med Genet</source><year>2005</year>
;
<volume>42</volume>
:
<fpage>358</fpage>
â
<lpage>65</lpage>
.
<pub-id pub-id-type="pmid">15805163</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B15">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cottenie</surname><given-names>E</given-names></name><name><surname>Kochanski</surname><given-names>A</given-names></name><name><surname>Jordanova</surname><given-names>A</given-names></name><name><surname>Bansagi</surname><given-names>B</given-names></name><name><surname>Zimon</surname><given-names>M</given-names></name><name><surname>Horga</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>
Truncating and missense mutations in
<italic>IGHMBP2</italic>
cause Charcot-Marie Tooth disease type 2
</article-title>
.
<source>Am J Hum Genet</source><year>2014</year>
;
<volume>95</volume>
:
<fpage>590</fpage>
â
<lpage>601</lpage>
.
<pub-id pub-id-type="pmid">25439726</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B17">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crimella</surname><given-names>C</given-names></name><name><surname>Baschirotto</surname><given-names>C</given-names></name><name><surname>Arnoldi</surname><given-names>A</given-names></name><name><surname>Tonelli</surname><given-names>A</given-names></name><name><surname>Tenderini</surname><given-names>E</given-names></name><name><surname>Airoldi</surname><given-names>G</given-names></name><etal/></person-group>
.
<article-title>
Mutations in the motor and stalk domains of
<italic>KIF5A</italic>
in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2
</article-title>
.
<source>Clin Genet</source><year>2012</year>
;
<volume>82</volume>
:
<fpage>157</fpage>
â
<lpage>64</lpage>
.
<pub-id pub-id-type="pmid">21623771</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B79">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daoud</surname><given-names>H</given-names></name>
,
<name><surname>Zhou</surname><given-names>S</given-names></name>
,
<name><surname>Noreau</surname><given-names>A</given-names></name>
,
<name><surname>Sabbagh</surname><given-names>M</given-names></name>
,
<name><surname>Belzil</surname><given-names>V</given-names></name>
,
<name><surname>Dionne-Laporte</surname><given-names>A</given-names></name>
, et al.
</person-group>
<article-title>Exome sequencing reveals SPG11 mutations causing juvenile ALS</article-title>
.
<source>Neurobiol Aging</source><year>2012</year>
;
<volume>33</volume>
:
<comment>839. e5â9</comment>
.
</mixed-citation>
      </ref>
      <ref id="awv320-B18">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Sandre-Giovannoli</surname><given-names>A</given-names></name><name><surname>Chaouch</surname><given-names>M</given-names></name><name><surname>Kozlov</surname><given-names>S</given-names></name><name><surname>Vallat</surname><given-names>JM</given-names></name><name><surname>Tazir</surname><given-names>M</given-names></name><name><surname>Kassouri</surname><given-names>N</given-names></name><etal/></person-group>
.
<article-title>
Homozygous defects in
<italic>LMNA</italic>
, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse
</article-title>
.
<source>Am J Hum Genet</source><year>2002</year>
;
<volume>70</volume>
:
<fpage>726</fpage>
â
<lpage>36</lpage>
.
<pub-id pub-id-type="pmid">11799477</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B19">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Del Bo</surname><given-names>R</given-names></name><name><surname>Di Fonzo</surname><given-names>A</given-names></name><name><surname>Ghezzi</surname><given-names>S</given-names></name><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Stevanin</surname><given-names>G</given-names></name><name><surname>Costa</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>SPG11: a consistent clinical phenotype in a family with homozygous spatacsin truncating mutation</article-title>
.
<source>Neurogenetics</source><year>2007</year>
;
<volume>8</volume>
:
<fpage>301</fpage>
â
<lpage>5</lpage>
.
<pub-id pub-id-type="pmid">17717710</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B20">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Denora</surname><given-names>PS</given-names></name><name><surname>Schlesinger</surname><given-names>D</given-names></name><name><surname>Casali</surname><given-names>C</given-names></name><name><surname>Kok</surname><given-names>F</given-names></name><name><surname>Tessa</surname><given-names>A</given-names></name><name><surname>Boukhris</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion</article-title>
.
<source>Hum Mutat</source><year>2009</year>
;
<volume>30</volume>
:
<fpage>500</fpage>
â
<lpage>19</lpage>
.
</mixed-citation>
      </ref>
      <ref id="awv320-B21">
        <mixed-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Dyck</surname><given-names>PJ</given-names></name><name><surname>Thomas</surname><given-names>PK</given-names></name></person-group>
, editors.
<source>Peripheal neuropathy</source>
. 4th edn.
<publisher-loc>Philadelphia, PA</publisher-loc>
:
<publisher-name>Elsevier Saunders</publisher-name>
;
<year>2005</year>
.
<comment><ext-link ext-link-type="uri" xlink:href="http://www.scribd.com/doc/243563627/Peripheral-Neuropathy-2005-Dyck-pdf#scribd">http://www.scribd.com/doc/243563627/Peripheral-Neuropathy-2005-Dyck-pdf#scribd</ext-link></comment></mixed-citation>
      </ref>
      <ref id="awv320-B22">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dyck</surname><given-names>PJ</given-names></name><name><surname>Gutrecht</surname><given-names>JA</given-names></name><name><surname>Bastron</surname><given-names>JA</given-names></name><name><surname>Karnes</surname><given-names>WE</given-names></name><name><surname>Dale</surname><given-names>AJ</given-names></name></person-group>
.
<article-title>Histologic and teased-fiber measurements of sural nerve in disorders of lower motor and primary sensory neurons</article-title>
.
<source>Mayo Clin Proc</source><year>1968</year>
;
<volume>43</volume>
:
<fpage>81</fpage>
â
<lpage>123</lpage>
.
<pub-id pub-id-type="pmid">4170683</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B23">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feely</surname><given-names>S</given-names></name><name><surname>Laura</surname><given-names>M</given-names></name><name><surname>Siskind</surname><given-names>CE</given-names></name><name><surname>Sottile</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>M</given-names></name><name><surname>Gibbons</surname><given-names>VS</given-names></name><etal/></person-group>
.
<article-title><italic>MFN2</italic>
mutations cause severe phenotypes in most patients with CMT2A
</article-title>
.
<source>Neurology</source><year>2011</year>
;
<volume>76</volume>
:
<fpage>1690</fpage>
â
<lpage>6</lpage>
.
<pub-id pub-id-type="pmid">21508331</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B24">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fridman</surname><given-names>V</given-names></name><name><surname>Murphy</surname><given-names>SM</given-names></name></person-group>
.
<article-title>The spectrum of axonopathies: from CMT2 to HSP</article-title>
.
<source>Neurology</source><year>2014</year>
;
<volume>83</volume>
:
<fpage>580</fpage>
â
<lpage>1</lpage>
.
<pub-id pub-id-type="pmid">25008393</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B25">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fusco</surname><given-names>C</given-names></name><name><surname>Frattini</surname><given-names>D</given-names></name><name><surname>Farnetti</surname><given-names>E</given-names></name><name><surname>Nicoli</surname><given-names>D</given-names></name><name><surname>Casali</surname><given-names>B</given-names></name><name><surname>Fiorentino</surname><given-names>F</given-names></name><etal/></person-group>
.
<article-title>
Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A
<italic>de novo</italic>
mutation
</article-title>
.
<source>Brain Dev</source><year>2010</year>
;
<volume>32</volume>
:
<fpage>592</fpage>
â
<lpage>4</lpage>
.
<pub-id pub-id-type="pmid">19735987</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B26">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Genari</surname><given-names>AB</given-names></name><name><surname>Borghetti</surname><given-names>VH</given-names></name><name><surname>GouvÃªa</surname><given-names>SP</given-names></name><name><surname>Bueno</surname><given-names>KC</given-names></name><name><surname>dos Santos</surname><given-names>PL</given-names></name><name><surname>dos Santos</surname><given-names>AC</given-names></name><etal/></person-group>
.
<article-title>
Characterizing the phenotypic manifestations of
<italic>MFN2</italic>
R104W mutation in Charcot-Marie-Tooth type 2
</article-title>
.
<source>Neuromuscul Disord</source><year>2011</year>
;
<volume>21</volume>
:
<fpage>428</fpage>
â
<lpage>32</lpage>
.
<pub-id pub-id-type="pmid">21531138</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B27">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gess</surname><given-names>B</given-names></name><name><surname>Auer-Grumbach</surname><given-names>M</given-names></name><name><surname>Schirmacher</surname><given-names>A</given-names></name><name><surname>Strom</surname><given-names>T</given-names></name><name><surname>Zitzelsberger</surname><given-names>M</given-names></name><name><surname>Rudnik-SchÃ¶neborn</surname><given-names>S</given-names></name><etal/></person-group>
.
<article-title><italic>HSJ1</italic>
-related hereditary neuropathies: novel mutations and extended clinical spectrum
</article-title>
.
<source>Neurology</source><year>2014</year>
;
<volume>83</volume>
:
<fpage>1726</fpage>
â
<lpage>32</lpage>
.
<pub-id pub-id-type="pmid">25274842</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B28">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goizet</surname><given-names>C</given-names></name><name><surname>Boukhris</surname><given-names>A</given-names></name><name><surname>Mundwiller</surname><given-names>E</given-names></name><name><surname>Tallaksen</surname><given-names>C</given-names></name><name><surname>Forlani</surname><given-names>S</given-names></name><name><surname>Toutain</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10</article-title>
.
<source>Hum Mutat</source><year>2009</year>
;
<volume>30</volume>
:
<fpage>376</fpage>
â
<lpage>85</lpage>
.
</mixed-citation>
      </ref>
      <ref id="awv320-B29">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guelly</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>PP</given-names></name><name><surname>Leonardis</surname><given-names>L</given-names></name><name><surname>PapiÄ</surname><given-names>L</given-names></name><name><surname>Zidar</surname><given-names>J</given-names></name><name><surname>SchabhÃ¼ttl</surname><given-names>M</given-names></name><etal/></person-group>
.
<article-title>Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I</article-title>
.
<source>Am J Hum Genet</source><year>2011</year>
;
<volume>88</volume>
:
<fpage>99</fpage>
â
<lpage>105</lpage>
.
<pub-id pub-id-type="pmid">21194679</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B30">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guernsey</surname><given-names>DL</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Bedard</surname><given-names>K</given-names></name><name><surname>Evans</surname><given-names>SC</given-names></name><name><surname>Ferguson</surname><given-names>M</given-names></name><name><surname>Matsuoka</surname><given-names>M</given-names></name><etal/></person-group>
.
<article-title>Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with Charcot-Marie-Tooth disease</article-title>
.
<source>PLoS Genet</source><year>2010</year>
;
<volume>6</volume>
:
<fpage>e1001081</fpage>
.
<pub-id pub-id-type="pmid">20865121</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B31">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hammer</surname><given-names>MB</given-names></name><name><surname>Eleuch-Fayache</surname><given-names>G</given-names></name><name><surname>Schottlaender</surname><given-names>LV</given-names></name><name><surname>Nehdi</surname><given-names>H</given-names></name><name><surname>Gibbs</surname><given-names>JR</given-names></name><name><surname>Arepalli</surname><given-names>SK</given-names></name><etal/></person-group>
.
<article-title>
Mutations in
<italic>GBA2</italic>
cause autosomal-recessive cerebellar ataxia with spasticity
</article-title>
.
<source>Am J Hum Genet</source><year>2013</year>
;
<volume>92</volume>
:
<fpage>245</fpage>
â
<lpage>51</lpage>
.
<pub-id pub-id-type="pmid">23332917</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B32">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanein</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Boukhris</surname><given-names>A</given-names></name><name><surname>Byrne</surname><given-names>P</given-names></name><name><surname>Goizet</surname><given-names>C</given-names></name><name><surname>Hamri</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome</article-title>
.
<source>Am J Hum Genet</source><year>2008</year>
;
<volume>82</volume>
:
<fpage>992</fpage>
â
<lpage>1002</lpage>
.
<pub-id pub-id-type="pmid">18394578</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B33">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hegele</surname><given-names>R</given-names></name></person-group>
.
<article-title><italic>LMNA</italic>
mutation position predicts organ system involvement in laminopathies
</article-title>
.
<source>Clin Genet</source><year>2005</year>
;
<volume>68</volume>
:
<fpage>31</fpage>
â
<lpage>4</lpage>
.
<pub-id pub-id-type="pmid">15952983</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B34">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hehr</surname><given-names>U</given-names></name><name><surname>Bauer</surname><given-names>P</given-names></name><name><surname>Winner</surname><given-names>B</given-names></name><name><surname>SchÃ¼le</surname><given-names>R</given-names></name><name><surname>Olmez</surname><given-names>A</given-names></name><name><surname>Koehler</surname><given-names>W</given-names></name><etal/></person-group>
.
<article-title>Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia</article-title>
.
<source>Ann Neurol</source><year>2007</year>
;
<volume>62</volume>
:
<fpage>656</fpage>
â
<lpage>65</lpage>
.
<pub-id pub-id-type="pmid">18067136</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B35">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirst</surname><given-names>J</given-names></name><name><surname>Borner</surname><given-names>GH</given-names></name><name><surname>Edgar</surname><given-names>J</given-names></name><name><surname>Hein</surname><given-names>MY</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><etal/></person-group>
.
<article-title>Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11and SPG15</article-title>
.
<source>Mol Biol Cell</source><year>2013</year>
;
<volume>24</volume>
:
<fpage>2558</fpage>
â
<lpage>69</lpage>
.
<pub-id pub-id-type="pmid">23825025</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B36">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Houlden</surname><given-names>H</given-names></name><name><surname>Laura</surname><given-names>M</given-names></name><name><surname>Wavrant-De VriÃ¨ze</surname><given-names>F</given-names></name><name><surname>Blake</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>N</given-names></name><name><surname>Reilly</surname><given-names>MM</given-names></name></person-group>
.
<article-title>
Mutations in the
<italic>HSP27</italic>
(
<italic>HSPB1</italic>
) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2
</article-title>
.
<source>Neurology</source><year>2008</year>
;
<volume>71</volume>
:
<fpage>1660</fpage>
â
<lpage>8</lpage>
.
<pub-id pub-id-type="pmid">18832141</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B37">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howard</surname><given-names>HC</given-names></name><name><surname>Mount</surname><given-names>DB</given-names></name><name><surname>Rochefort</surname><given-names>D</given-names></name><name><surname>Byun</surname><given-names>N</given-names></name><name><surname>DuprÃ©</surname><given-names>N</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><etal/></person-group>
.
<article-title>The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum</article-title>
.
<source>Nat Genet</source><year>2002</year>
;
<volume>32</volume>
:
<fpage>384</fpage>
â
<lpage>92</lpage>
.
<comment>Erratum in Nat Genet 2002; 32: 681</comment>
.
<pub-id pub-id-type="pmid">12368912</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B38">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ito</surname><given-names>D</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name></person-group>
.
<article-title>Seipinopathy: a novel endoplasmic reticulum stress-associated disease [Review]</article-title>
.
<source>Brain</source><year>2009</year>
;
<volume>132</volume>
:
<fpage>8</fpage>
â
<lpage>15</lpage>
.
<pub-id pub-id-type="pmid">18790819</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B39">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jerath</surname><given-names>NU</given-names></name><name><surname>Shy</surname><given-names>ME</given-names></name></person-group>
.
<article-title>Hereditary motor and sensory neuropathies: Understanding molecular pathogenesis could lead to future treatment strategies</article-title>
.
<source>Biochim Biophys Acta</source><year>2015</year>
;
<volume>1852</volume>
:
<fpage>667</fpage>
â
<lpage>78</lpage>
.
<pub-id pub-id-type="pmid">25108281</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B40">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>LandourÃ©</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>PP</given-names></name><name><surname>LourenÃ§o</surname><given-names>CM</given-names></name><name><surname>Johnson</surname><given-names>JO</given-names></name><name><surname>Toro</surname><given-names>C</given-names></name><name><surname>Bricceno</surname><given-names>KV</given-names></name><etal/></person-group>
.
<article-title>
Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in
<italic>C19orf12</italic></article-title>
.
<source>Hum Mutat</source><year>2013</year>
;
<volume>34</volume>
:
<fpage>1357</fpage>
â
<lpage>60</lpage>
.
<pub-id pub-id-type="pmid">23857908</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B41">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leal</surname><given-names>A</given-names></name><name><surname>Huehne</surname><given-names>K</given-names></name><name><surname>Bauer</surname><given-names>F</given-names></name><name><surname>Sticht</surname><given-names>H</given-names></name><name><surname>Berger</surname><given-names>P</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name><etal/></person-group>
.
<article-title>
Identification of the variant Ala335Val of
<italic>MED25</italic>
as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type
<italic>MED25</italic>
and
<italic>PMP22</italic>
RNA levels in CMT1A animal models
</article-title>
.
<source>Neurogenetics</source><year>2009</year>
;
<volume>10</volume>
:
<fpage>275</fpage>
â
<lpage>87</lpage>
.
<pub-id pub-id-type="pmid">19290556</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B42">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Cheng</surname><given-names>TW</given-names></name><name><surname>Hua</surname><given-names>MS</given-names></name><name><surname>Pan</surname><given-names>MK</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Stephenson</surname><given-names>DA</given-names></name><etal/></person-group>
.
<article-title>Mutations of the SPG11 gene in patients with autosomal recessive spastic paraparesis and thin corpus callosum</article-title>
.
<source>J Neurol Neurosurg Psychiatry</source><year>2008</year>
;
<volume>79</volume>
:
<fpage>607</fpage>
â
<lpage>9</lpage>
.
<pub-id pub-id-type="pmid">18408091</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B43">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leonardis</surname><given-names>L</given-names></name><name><surname>Auer-Grumbach</surname><given-names>M</given-names></name><name><surname>PapiÄ</surname><given-names>L</given-names></name><name><surname>Zidar</surname><given-names>J</given-names></name></person-group>
.
<article-title>The N355K atlastin 1 mutation is associated with hereditary sensory neuropathy and pyramidal tract features</article-title>
.
<source>Eur J Neurol</source><year>2012</year>
;
<volume>19</volume>
:
<fpage>992</fpage>
â
<lpage>8</lpage>
.
<pub-id pub-id-type="pmid">22340599</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B44">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lo Giudice</surname><given-names>T</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>Santorelli</surname><given-names>FM</given-names></name><name><surname>Kawarai</surname><given-names>T</given-names></name><name><surname>Orlacchio</surname><given-names>A</given-names></name></person-group>
.
<article-title>Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms [Review]</article-title>
.
<source>Exp Neurol</source><year>2014</year>
;
<volume>261</volume>
:
<fpage>518</fpage>
â
<lpage>39</lpage>
.
<pub-id pub-id-type="pmid">24954637</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B45">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>SchÃ¼le</surname><given-names>R</given-names></name><name><surname>Smets</surname><given-names>K</given-names></name><name><surname>Rastetter</surname><given-names>A</given-names></name><name><surname>Boukhris</surname><given-names>A</given-names></name><name><surname>Loureiro</surname><given-names>JL</given-names></name><etal/></person-group>
.
<article-title>
Loss of function of glucocerebrosidase
<italic>GBA2</italic>
is responsible for motor neuron defects in hereditary spastic paraplegia
</article-title>
.
<source>Am J Hum Genet</source><year>2013</year>
;
<volume>92</volume>
:
<fpage>238</fpage>
â
<lpage>44</lpage>
.
<pub-id pub-id-type="pmid">23332916</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B46">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Yanicostas</surname><given-names>C</given-names></name><name><surname>Rastetter</surname><given-names>A</given-names></name><name><surname>Naini</surname><given-names>SM</given-names></name><name><surname>Maouedj</surname><given-names>A</given-names></name><name><surname>Kabashi</surname><given-names>E</given-names></name><etal/></person-group>
.
<article-title>Spatacsin and spastizin act in the same pathway required for proper spinal motor neuron axon outgrowth in Zebrafish</article-title>
.
<source>Neurobiol Dis</source><year>2012</year>
;
<volume>48</volume>
:
<fpage>299</fpage>
â
<lpage>308</lpage>
.
<pub-id pub-id-type="pmid">22801083</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B47">
        <mixed-citation publication-type="book">
<collab>Medical Research Council</collab>
.
<article-title>Aids to the examination of the peripheral nervous system</article-title>
.
<publisher-name>Her Majesty's Stationery Office</publisher-name>
.
<publisher-loc>London, UK</publisher-loc>
;
<year>1981</year>
,
<comment>Memorandum no. 45</comment>
.
</mixed-citation>
      </ref>
      <ref id="awv320-B48">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murphy</surname><given-names>SM</given-names></name><name><surname>Herrmann</surname><given-names>DN</given-names></name><name><surname>McDermott</surname><given-names>MP</given-names></name><name><surname>Scherer</surname><given-names>SS</given-names></name><name><surname>Shy</surname><given-names>ME</given-names></name><name><surname>Reilly</surname><given-names>MM</given-names></name><etal/></person-group>
.
<article-title>Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease</article-title>
.
<source>J Peripher Nerv Syst</source><year>2011</year>
;
<volume>16</volume>
:
<fpage>191</fpage>
â
<lpage>8</lpage>
.
<pub-id pub-id-type="pmid">22003934</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B49">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>GA</given-names></name><name><surname>Magdelaine</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>D</given-names></name><name><surname>Grew</surname><given-names>S</given-names></name><name><surname>Ryan</surname><given-names>MM</given-names></name><name><surname>Sturtz</surname><given-names>F</given-names></name><etal/></person-group>
.
<article-title>
Severe early-onset axonal neuropathy with homozygous and compound heterozygous
<italic>MFN2</italic>
mutations
</article-title>
.
<source>Neurology</source><year>2008</year>
;
<volume>70</volume>
:
<fpage>1678</fpage>
â
<lpage>81</lpage>
.
<pub-id pub-id-type="pmid">18458227</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B50">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nishino</surname><given-names>I</given-names></name><name><surname>Spinazzola</surname><given-names>A</given-names></name><name><surname>Papadimitriou</surname><given-names>A</given-names></name><name><surname>Hammans</surname><given-names>S</given-names></name><name><surname>Steiner</surname><given-names>I</given-names></name><name><surname>Hahn</surname><given-names>CD</given-names></name><etal/></person-group>
.
<article-title>Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations</article-title>
.
<source>Ann Neurol</source><year>2000</year>
;
<volume>47</volume>
:
<fpage>792</fpage>
â
<lpage>800</lpage>
.
<pub-id pub-id-type="pmid">10852545</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B51">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Orlacchio</surname><given-names>A</given-names></name><name><surname>Patrono</surname><given-names>C</given-names></name><name><surname>Gaudiello</surname><given-names>F</given-names></name><name><surname>Rocchi</surname><given-names>C</given-names></name><name><surname>Moschella</surname><given-names>V</given-names></name><name><surname>Floris</surname><given-names>R</given-names></name><etal/></person-group>
.
<article-title>Silver syndrome variant of hereditary spastic paraplegia: a locus to 4p and allelism with SPG4</article-title>
.
<source>Neurology</source><year>2008</year>
;
<volume>70</volume>
:
<fpage>1959</fpage>
â
<lpage>66</lpage>
.
<pub-id pub-id-type="pmid">18401025</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B52">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Orlacchio</surname><given-names>A</given-names></name><name><surname>Babalini</surname><given-names>C</given-names></name><name><surname>Borreca</surname><given-names>A</given-names></name><name><surname>Patrono</surname><given-names>C</given-names></name><name><surname>Massa</surname><given-names>R</given-names></name><name><surname>Basaran</surname><given-names>S</given-names></name><etal/></person-group>
.
<article-title>Spatacsin mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis</article-title>
.
<source>Brain</source><year>2010</year>
;
<volume>133</volume>
:
<fpage>591</fpage>
â
<lpage>8</lpage>
.
<pub-id pub-id-type="pmid">20110243</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B53">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ott</surname><given-names>J</given-names></name></person-group>
.
<article-title>Linkage analysis and family classification under heterogeneity</article-title>
.
<source>Ann Hum Genet</source><year>1983</year>
;
<volume>47</volume>
:
<fpage>311</fpage>
â
<lpage>20</lpage>
.
<pub-id pub-id-type="pmid">6651220</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B54">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palumbo</surname><given-names>C</given-names></name><name><surname>Massa</surname><given-names>R</given-names></name><name><surname>Panico</surname><given-names>MB</given-names></name><name><surname>Di Muzio</surname><given-names>A</given-names></name><name><surname>Sinibaldi</surname><given-names>P</given-names></name><name><surname>Bernardi</surname><given-names>G</given-names></name><etal/></person-group>
.
<article-title>Peripheral nerve extracellular matrix remodelling in Charcot-Marie-Tooth type I disease</article-title>
.
<source>Acta Neuropathol</source><year>2002</year>
;
<volume>104</volume>
:
<fpage>287</fpage>
â
<lpage>96</lpage>
.
<pub-id pub-id-type="pmid">12172915</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B55">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paisan-Ruiz</surname><given-names>C</given-names></name><name><surname>Nath</surname><given-names>P</given-names></name><name><surname>Wood</surname><given-names>NW</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Houlden</surname><given-names>H</given-names></name></person-group>
.
<article-title>Clinical heterogeneity and genotype-phenotype correlations in hereditary spastic paraplegia because of spatacsin mutations (SPG11)</article-title>
.
<source>Eur J Neurol</source><year>2008</year>
;
<volume>15</volume>
:
<fpage>1065</fpage>
â
<lpage>70</lpage>
.
<pub-id pub-id-type="pmid">18717728</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B56">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pehlivan</surname><given-names>D</given-names></name><name><surname>Coban Akdemir</surname><given-names>Z</given-names></name><name><surname>Karaca</surname><given-names>E</given-names></name><name><surname>Bayram</surname><given-names>Y</given-names></name><name><surname>Jhangiani</surname><given-names>S</given-names></name><name><surname>Yildiz</surname><given-names>EP</given-names></name><etal/></person-group>
.
<article-title>
Exome sequencing reveals homozygous
<italic>TRIM2</italic>
mutation in a patient with early onset CMT and bilateral vocal cord paralysis
</article-title>
.
<source>Hum Genet</source><year>2015</year>
;
<volume>134</volume>
:
<fpage>671</fpage>
â
<lpage>3</lpage>
.
<pub-id pub-id-type="pmid">25893792</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B57">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pensato</surname><given-names>V</given-names></name><name><surname>Castellotti</surname><given-names>B</given-names></name><name><surname>Gellera</surname><given-names>C</given-names></name><name><surname>Pareyson</surname><given-names>D</given-names></name><name><surname>Ciano</surname><given-names>C</given-names></name><name><surname>Nanetti</surname><given-names>L</given-names></name><etal/></person-group>
.
<article-title>Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48</article-title>
.
<source>Brain</source><year>2014</year>
;
<volume>137</volume>
:
<fpage>1907</fpage>
â
<lpage>20</lpage>
.
<pub-id pub-id-type="pmid">24833714</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B58">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>PÃ©rez-BrangulÃ­</surname><given-names>F</given-names></name><name><surname>Mishra</surname><given-names>HK</given-names></name><name><surname>Prots</surname><given-names>I</given-names></name><name><surname>Havlicek</surname><given-names>S</given-names></name><name><surname>Kohl</surname><given-names>Z</given-names></name><name><surname>Saul</surname><given-names>D</given-names></name><etal/></person-group>
.
<article-title>Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia</article-title>
.
<source>Hum Mol Genet</source><year>2014</year>
;
<volume>23</volume>
:
<fpage>4859</fpage>
â
<lpage>74</lpage>
.
<pub-id pub-id-type="pmid">24794856</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B59">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pierson</surname><given-names>TM</given-names></name><name><surname>Simeonov</surname><given-names>DR</given-names></name><name><surname>Sincan</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>DA</given-names></name><name><surname>Markello</surname><given-names>T</given-names></name><name><surname>Golas</surname><given-names>G</given-names></name><etal/></person-group>
.
<article-title>Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration</article-title>
.
<source>Eur J Hum Genet</source><year>2012</year>
;
<volume>20</volume>
:
<fpage>476</fpage>
â
<lpage>9</lpage>
.
<pub-id pub-id-type="pmid">22146942</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B60">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pippucci</surname><given-names>T</given-names></name><name><surname>Panza</surname><given-names>E</given-names></name><name><surname>Pompilii</surname><given-names>E</given-names></name><name><surname>Donadio</surname><given-names>V</given-names></name><name><surname>Borreca</surname><given-names>A</given-names></name><name><surname>Babalini</surname><given-names>C</given-names></name><etal/></person-group>
.
<article-title>Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity</article-title>
.
<source>Eur J Neurol</source><year>2009</year>
;
<volume>16</volume>
:
<fpage>121</fpage>
â
<lpage>6</lpage>
.
<pub-id pub-id-type="pmid">19087158</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B61">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Querin</surname><given-names>G</given-names></name><name><surname>Bertolin</surname><given-names>C</given-names></name><name><surname>Martinuzzi</surname><given-names>A</given-names></name><name><surname>Bassi</surname><given-names>MT</given-names></name><name><surname>Arnoldi</surname><given-names>A</given-names></name><name><surname>Polo</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>The blurred scenario of motor neuron disorders linked to spatacsin mutations: a case report</article-title>
.
<source>Eur J Neurol</source><year>2014</year>
;
<volume>21</volume>
:
<fpage>85</fpage>
â
<lpage>6</lpage>
.
</mixed-citation>
      </ref>
      <ref id="awv320-B62">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reyes-Marin</surname><given-names>K</given-names></name><name><surname>Jimenez-Pancho</surname><given-names>J</given-names></name><name><surname>Pozo</surname><given-names>L</given-names></name><name><surname>Garcia-Villanueva</surname><given-names>M</given-names></name><name><surname>de Blas</surname><given-names>G</given-names></name><name><surname>Vazquez</surname><given-names>JM</given-names></name><name><surname>Jimenez-Escrig</surname><given-names>A</given-names></name></person-group>
.
<article-title>A novel myelin protein zero (V136G) homozygous mutation causing late onset demyelinating polyneuropathy with brain white matter lesions</article-title>
.
<source>Clin Neurol Neurosurg</source><year>2011</year>
;
<volume>113</volume>
:
<fpage>243</fpage>
â
<lpage>4</lpage>
.
<pub-id pub-id-type="pmid">21277678</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B63">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sagnelli</surname><given-names>A</given-names></name><name><surname>Piscosquito</surname><given-names>G</given-names></name><name><surname>Chiapparini</surname><given-names>L</given-names></name><name><surname>Ciano</surname><given-names>C</given-names></name><name><surname>Salsano</surname><given-names>E</given-names></name><name><surname>Saveri</surname><given-names>P</given-names></name><etal/></person-group>
.
<article-title>
X-linked Charcot-Marie-Tooth type 1: stroke-like presentation of a novel
<italic>GJB1</italic>
mutation
</article-title>
.
<source>J Peripher Nerv Syst</source><year>2014</year>
;
<volume>19</volume>
:
<fpage>183</fpage>
â
<lpage>6</lpage>
.
<pub-id pub-id-type="pmid">24863494</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B65">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simpson</surname><given-names>MA</given-names></name><name><surname>Cross</surname><given-names>H</given-names></name><name><surname>Proukakis</surname><given-names>C</given-names></name><name><surname>Pryde</surname><given-names>A</given-names></name><name><surname>Hershberger</surname><given-names>R</given-names></name><name><surname>Chatonnet</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>Maspardin is mutated in mast syndrome, a complicated form of Hereditary Spastic Paraplegia associated with dementia</article-title>
.
<source>Am J Hum Genet</source><year>2003</year>
;
<volume>73</volume>
:
<fpage>1147</fpage>
â
<lpage>56</lpage>
.
<pub-id pub-id-type="pmid">14564668</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B66">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spiegel</surname><given-names>R</given-names></name><name><surname>Mandel</surname><given-names>H</given-names></name><name><surname>Saada</surname><given-names>A</given-names></name><name><surname>Lerer</surname><given-names>I</given-names></name><name><surname>Burger</surname><given-names>A</given-names></name><name><surname>Shaag</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>
Delineation of
<italic>C12orf65</italic>
-related phenotypes: a genotype-phenotype relationship
</article-title>
.
<source>Eur J Hum Genet</source><year>2014</year>
;
<volume>22</volume>
:
<fpage>1019</fpage>
â
<lpage>25</lpage>
.
<pub-id pub-id-type="pmid">24424123</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B67">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stevanin</surname><given-names>G</given-names></name><name><surname>Santorelli</surname><given-names>FM</given-names></name><name><surname>Azzedine</surname><given-names>H</given-names></name><name><surname>Coutinho</surname><given-names>P</given-names></name><name><surname>Chomilier</surname><given-names>J</given-names></name><name><surname>Denora</surname><given-names>PS</given-names></name><etal/></person-group>
.
<article-title>Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum</article-title>
.
<source>Nat Genet</source><year>2007a</year>
;
<volume>39</volume>
:
<fpage>366</fpage>
â
<lpage>72</lpage>
.
<pub-id pub-id-type="pmid">17322883</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B68">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stevanin</surname><given-names>G</given-names></name><name><surname>Azzedine</surname><given-names>H</given-names></name><name><surname>Denora</surname><given-names>P</given-names></name><name><surname>Boukhris</surname><given-names>A</given-names></name><name><surname>Tazir</surname><given-names>M</given-names></name><name><surname>Lossos</surname><given-names>A</given-names></name><etal/></person-group>
.
<article-title>Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration</article-title>
.
<source>Brain</source><year>2007b</year>
;
<volume>131</volume>
:
<fpage>772</fpage>
â
<lpage>84</lpage>
.
<pub-id pub-id-type="pmid">18079167</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B69">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tamiya</surname><given-names>G</given-names></name><name><surname>Makino</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>M</given-names></name><name><surname>Abe</surname><given-names>A</given-names></name><name><surname>Numakura</surname><given-names>C</given-names></name><name><surname>Ueki</surname><given-names>M</given-names></name><etal/></person-group>
.
<article-title>
A Mutation of
<italic>COX6A1</italic>
causes a recessive axonal or mixed form of Charcot-Marie-Tooth Disease
</article-title>
.
<source>Am J Hum Genet</source><year>2014</year>
;
<volume>95</volume>
:
<fpage>294</fpage>
â
<lpage>300</lpage>
.
<pub-id pub-id-type="pmid">25152455</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B70">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tazir</surname><given-names>M</given-names></name><name><surname>Bellatache</surname><given-names>M</given-names></name><name><surname>Nouioua</surname><given-names>S</given-names></name><name><surname>Vallat</surname><given-names>JM</given-names></name></person-group>
.
<article-title>Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes</article-title>
.
<source>J Peripher Nerv Syst</source><year>2013</year>
;
<volume>18</volume>
:
<fpage>113</fpage>
â
<lpage>29</lpage>
.
<pub-id pub-id-type="pmid">23781959</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B71">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tazir</surname><given-names>M</given-names></name><name><surname>Hamadouche</surname><given-names>T</given-names></name><name><surname>Nouioua</surname><given-names>S</given-names></name><name><surname>Mathis</surname><given-names>S</given-names></name><name><surname>Vallat</surname><given-names>JM</given-names></name></person-group>
.
<article-title>Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update</article-title>
.
<source>J Neurol Sci</source><year>2014</year>
;
<volume>347</volume>
:
<fpage>14</fpage>
â
<lpage>22</lpage>
.
<pub-id pub-id-type="pmid">25454638</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B72">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tessa</surname><given-names>A</given-names></name><name><surname>Denora</surname><given-names>PS</given-names></name><name><surname>Racis</surname><given-names>L</given-names></name><name><surname>Storti</surname><given-names>E</given-names></name><name><surname>Orlacchio</surname><given-names>A</given-names></name><name><surname>Santorelli</surname><given-names>FM</given-names></name></person-group>
.
<article-title>Bridging over the troubled heterogeneity of SPG-related pathologies: mechanisms unite what genetics divide [Review]</article-title>
.
<source>Curr Mol Med</source><year>2014</year>
;
<volume>14</volume>
:
<fpage>1034</fpage>
â
<lpage>42</lpage>
.
<pub-id pub-id-type="pmid">25323869</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B73">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tesson</surname><given-names>C</given-names></name><name><surname>Nawara</surname><given-names>M</given-names></name><name><surname>Salih</surname><given-names>MAM</given-names></name><name><surname>Rossignol</surname><given-names>R</given-names></name><name><surname>Zaki</surname><given-names>MS</given-names></name><name><surname>Al Balwi</surname><given-names>M</given-names></name><etal/></person-group>
.
<article-title>Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia</article-title>
.
<source>Am J Hum Genet</source><year>2012</year>
;
<volume>91</volume>
:
<fpage>1051</fpage>
â
<lpage>64</lpage>
.
<pub-id pub-id-type="pmid">23176821</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B74">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Timmerman</surname><given-names>V</given-names></name><name><surname>Clowes</surname><given-names>VE</given-names></name><name><surname>Reid</surname><given-names>E</given-names></name></person-group>
.
<article-title>Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias [Review]</article-title>
.
<source>Exp Neurol</source><year>2013</year>
;
<volume>246</volume>
:
<fpage>14</fpage>
â
<lpage>25</lpage>
.
<pub-id pub-id-type="pmid">22285450</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B75">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Goethem</surname><given-names>G</given-names></name><name><surname>Dermaut</surname><given-names>B</given-names></name><name><surname>LÃ¶fgren</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>JJ</given-names></name><name><surname>Van Broeckhoven</surname><given-names>C</given-names></name></person-group>
.
<article-title>
Mutation of
<italic>POLG</italic>
is associated with progressive external ophthalmoplegia characterized by mtDNA deletions
</article-title>
.
<source>Nat Genet</source><year>2001</year>
;
<volume>28</volume>
:
<fpage>211</fpage>
â
<lpage>2</lpage>
.
<pub-id pub-id-type="pmid">11431686</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B76">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yum</surname><given-names>SW</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Mo</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Scherer</surname><given-names>SS</given-names></name></person-group>
.
<article-title>
A novel recessive
<italic>NEFL</italic>
mutation causes a severe, early-onset axonal neuropathy
</article-title>
.
<source>Ann Neurol</source><year>2009</year>
;
<volume>66</volume>
:
<fpage>759</fpage>
â
<lpage>70</lpage>
.
<pub-id pub-id-type="pmid">20039262</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B77">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Windpassinger</surname><given-names>C</given-names></name><name><surname>Auer-Grumbach</surname><given-names>M</given-names></name><name><surname>Irobi</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>H</given-names></name><name><surname>Petek</surname><given-names>E</given-names></name><name><surname>HÃ¶rl</surname><given-names>G</given-names></name><etal/></person-group>
.
<article-title>
Heterozygous missense mutations in
<italic>BSCL2</italic>
are associated with distal hereditary motor neuropathy and Silver syndrome
</article-title>
.
<source>Nat Genet</source><year>2004</year>
;
<volume>36</volume>
:
<fpage>271</fpage>
â
<lpage>6</lpage>
.
<pub-id pub-id-type="pmid">14981520</pub-id></mixed-citation>
      </ref>
      <ref id="awv320-B78">
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>ZimoÅ</surname><given-names>M1</given-names></name><name><surname>Baets</surname><given-names>J</given-names></name><name><surname>Almeida-Souza</surname><given-names>L</given-names></name><name><surname>De Vriendt</surname><given-names>E</given-names></name><name><surname>Nikodinovic</surname><given-names>J</given-names></name><name><surname>Parman</surname><given-names>Y</given-names></name><etal/></person-group>
.,
<article-title>
Loss-of-function mutations in
<italic>HINT1</italic>
cause axonal neuropathy with neuromyotonia
</article-title>
.
<source>Nat Genet</source><year>2012</year>
:
<volume>44</volume>
:
<fpage>1080</fpage>
â
<lpage>3</lpage>
.
<pub-id pub-id-type="pmid">22961002</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>